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ABSTRACT
There is support in the literature for motivational enhancement therapy (MET) as
an acceptable method for achieving abstinence and increasing retention in therapy for the
treatment of marijuana and alcohol abuse, and for contingency management (CM) as a
useful tool for enhancing both of these objectives when combined with empirically
supported therapies such as MET. However, MET combined with CM had yet to be
tested with substance using adolescents and young adults enrolled in a substance use
program in a vocational and educational training facility.
This study examined the effectiveness of an MET and CM program designed to
provide opportunities to win prizes to reinforce therapy attendance and submission of
urine samples that were negative for marijuana. Fourteen (N=14) individuals from a
vocational training center who tested positive for marijuana on their initial drug screen
were assigned to receive either standard treatment (ST), or CM plus MET in addition to
ST. The retention rates of twenty-two (N=22) non-randomized participants who had
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tested positive for marijuana upon entry to the training center were also compared to the
retention rates of the study participants.
The MET+CM+ST group demonstrated significantly higher study drug screen
pass rates at 1- and 3-month follow-ups, and significantly greater percent days abstinent
(PDA) for marijuana at the 3-month follow-up compared to the ST group. In addition,
the percentage of trainees who successfully passed their second official drug screen and
were therefore retained and able to continue their training at the Job Corps was
significantly higher for those who consented into the study than the non-randomized
participant group; however, there were no statistical differences found between the study
groups in retention, largely due to administrative leniency extended to the ST group by
the training program.
Originally, incoming trainees who were on probation for alcohol use were to be
included in the study as well, however none of the incoming trainees were on probation
due to alcohol use during the duration of this study. Also, there was very little alcohol
use reported by the participants who were enrolled in the study, and there were no
significant findings regarding alcohol use.
The study results build upon prior research and offer an initial exploratory
analysis of the efficacy of MET and CM with trainees from a vocational program who
tested positive for marijuana, and highlights recommendations for developing
interventions to facilitate abstinence in a real life, non-clinical setting.
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Eliciting Abstinence and Improving Retention in a Vocational and Educational Training
Program for Young People: A Pilot Study
The Job Corps is a federally funded, no-cost education and vocational training
program assisting low-income young people (ages 16-24) in restructuring their lives and
getting a better job. Nationally, there are a total of 122 centers and approximately 62,000
individuals are enrolled each year. The average Job Corps trainee is an 18-year old
minority, high school dropout, who reads at the 7th grade level who has never held a fulltime job. Approximately 70% of all Job Corps enrollees are minorities; 75% are high
school dropouts, and more than 30% receive public assistance
(http://www.allgov.com/agency/Job_ Corps, retrieved on January 24, 2010).
In addition to educational and vocational training, students receive medical and
dental care, driver’s education, social skills training, housing, meals, clothing allowance,
child care, and recreational and leadership opportunities. Students enroll to learn a trade
and to work concurrently toward their GED or high school diploma. In this program, bimonthly small incentives ($25) in the form of allowances are awarded, and the amount
increases gradually for each month of successful participation in the program. Upon
graduation from the program, the Job Corps provides career counseling and transition
support for up to 12 months.
Individuals are eligible for recruitment into the Job Corps if they meet one or
more of the following criteria: 1) dropped out of school, 2) require additional assistance
to successfully participate in regular schoolwork or employment, 3) are basic skills
deficient, 4) are a homeless, runaway, or foster child, or 5) are a parent (Policy and
Requirements Handbook, Job Corps (PRH) (2001), 1.2, pp. 1-2). Also, they cannot have
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any current outstanding serious criminal or court involvement (e.g., probation or warrants
for arrest).
As of January 8, 2008, there were 429 students enrolled in the Albuquerque Job
Corps Center. This center offers career training opportunities in the following fields:
business office technologies, carpentry, cement masonry, data entry, electrician, facilities
maintenance, nurse’s aide, medical assistant, painter, plasterer, plumbing and welding.
Career training includes hands-on experience and work-based learning opportunities. In
addition, students may take advanced courses at the local community college.
The typical time to graduation for this center is 8-12 months; if necessary
individuals may take up to 2 years to complete their training. At the Albuquerque Job
Corps Center, students completing the probationary period of 60 days stay an average of
282 days in the program, and of those nearly 50% graduate. Nationally, 82% graduate
and spend an average of 234 days in the program. A graduate is a person who has
completed 60 or more days of enrollment and if needed, has earned their GED or high
school diploma, and/or completed their vocational training (PRH, Chapter 5, Appendix
501, page 3). At the Albuquerque Center, approximately 25% of incoming trainees do
not complete the probationary period, mainly due to substance use issues. Nationally,
approximately 18% of all new Job Corps students depart the program within the first 60
days of enrollment due to a variety of reasons (e.g. failure to adapt, homesickness,
medical, violations of substance use policy)
(http://www.jobcorps.gov/Libraries/pdf/py06report.sflb, retrieved on January 24, 2010).
The Job Corps is an individualized, self-paced learning environment, and
admission and graduation occur on a rolling basis. Once admitted into the program,
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individuals can only be tested for substance use within the first 48-hours of being at the
center (“initial drug screen”), and if they test negative, thereafter only upon suspicion.
Should they test positive on their initial drug screen, they are then placed on probation
and re-tested in approximately 5-6 weeks. At the Albuquerque Job Corps Center trainees
are tested within the first 24 hours of being on campus and results of the screen are
returned in one week. Of the 12 individuals admitted on average into the program
weekly, typically 3-5 of those individuals fail their initial drug screen or indicate on their
initial pre-screen that they have abused substances in the past 60 days.
The Job Corps has a Zero Tolerance drug and alcohol policy. According to
program protocol, individuals failing their initial drug screen are re-tested near the end of
their 45-day probationary period, or sooner upon suspicion of use. The Albuquerque Job
Corps re-tests on day 38. Should they submit a second positive urinalysis then or at any
time, they must exit the program. Trainees testing positive on entry or later during the
probationary period, or who are self-referred and recommended by the Trainee Employee
Assistance Program (TEAP) specialist, are permitted the option of a medical separation
with reinstatement (MSWR), which allows them to return to Job Corps in six months if
they provide proof of successful completion of treatment for substance use and provide a
negative drug screen (Policy and Requirement Handbook; PRH, Chapter 6, 11-2, pp. 56).
As previously stated, the Albuquerque Center graduates approximately 50% of
those completing the probationary period, and of those completing probation and failing
to graduate, more than half are due to drug and alcohol use. And, approximately 50% of
those initially failing their drug screen, test positive on their re-test and are forced to exit
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the program. The preferred drugs of abuse for these individuals are marijuana and
alcohol. Nationally, the Albuquerque Center leads the Job Corps centers in alcohol and
drug related incidents.
The Albuquerque Center recruits the majority of their trainees from New Mexico.
According to a survey by the National Families in Action (2001), New Mexico is 3rd on
the list of states with the highest percentage of the population reporting past year illicit
drug or alcohol use disorders (6.5%). Additionally, New Mexico is ranked 5th in the
nation for the highest rate of violent crimes, and many of those crimes involved substance
use (U.S. Drug Enforcement Agency; DEA, 2007). In 2006, 38% of all motor vehicle
traffic fatalities in New Mexico were alcohol-related (National Highway Traffic Safety
Administration; NHTSA, 2007). During the period of 2004-2006, New Mexico ranked
3rd for the highest poverty rate only behind the states of Alabama and Louisiana (U.S.
Census Bureau, 2006). New Mexico also is ranked 4th in the country for the highest rate
of completed suicides, with a rate of 18.4 per 100,000 persons (American Association of
Suicidology, 2006a). Alcohol use disorders also are correlated with suicide, and the risk
of suicide in alcoholics is estimated to be 50-70% higher than the general population
(American Association of Suicidology, 2006b).
Based on a 2002-2003 National Survey on Drug Use and Health (SAMHSA,
2005), an estimated 47,000 individuals ages 18-25 in New Mexico were reported to have
an illicit drug dependence or abuse problem in a 1-month period, and approximately
25,000 individuals between the ages of 12-17 years. In addition, heavy alcohol
consumption is a factor in 69% of all completed suicides in New Mexico among the
American Indian population (May et al., 2002). Also, American Indians are more likely
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to report addictions, and approximately one-half of the trainees at the Job Corps are of
this ethnic group.
Therefore, many of the potential recruits have had direct or indirect experiences
with drug use and abuse. In addition, the majority of the young people enrolled in the
Albuquerque Center have either dropped out or been expelled from the public school
system, mainly due to excessive absences, criminal activity, and/or drug use. All of the
trainees come from impoverished backgrounds and many were considered homeless upon
enrollment. For most, this is their first opportunity for a structured, positive lifestyle in
which they can earn their high school diploma, GED, and receive career training.
Unfortunately, many promising recruits are expelled from the program due to an inability
to remain alcohol and drug free during the probationary period. Improving upon the
existing drug treatment program at Job Corps could help many of those recruits stay in
the program and perhaps change the course of their lives.
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Literature Review

The purpose of this review is to examine empirical support for MET and CM as
found in published, controlled studies that focused on either marijuana or alcohol, as
these were the two primary drugs of choice with Job Corps trainees at the Albuquerque
Center. To date, there is little published research on treating substance use disorders with
the Job Corps population and there are no empirically supported treatments for this
population.
Background
Motivational enhancement therapy (MET).
In MET, clinicians embrace an empathetic, Rogerian, person-centered therapeutic
style in which they avoid resistance and argumentation, resolve ambivalence, heighten
discrepancies about personal goals and current behaviors, and elicit motivation to change
(Miller & Rollnick, 2002). MET has been applied to a range of medical and behavioral
disorders including therapy for drug use disorders, diabetes and hypertension
management, bulimia nervosa, and risky sexual behavior (Heather, 2005).
MET is believed to be an effective approach for changing addictive behavior
based on the idea that addiction is a disorder of motivation. And, the behavior of
immediate drug use is preferred over other priorities or long-term interests. MET
attempts to address the motivational conflict behind one’s stated desires and
contradictory behaviors through exploration and self-realization of the problem. MET
embraces the concept that the therapist cannot directly cause change, but rather, the client
has that power. The therapist simply guides the client from the pre-contemplative stage
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to contemplation, determination, action and then towards maintenance (Prochaska &
DiClemente, 1982).
The use of self-reflection in MET allows for a wide range of issues to arise
naturally during therapy. This type of therapy provides people who are not actively
seeking treatment for a particular problem with the psychological space to realize that
some sort of assistance may be required to resolve an issue that is troubling them. Giving
direct advice is avoided by an MET therapist and behavioral change is dictated by the
client, which subsequently, may result in a reduction in drug use rather than complete
abstinence, a more desirable goal for some problem users who are not ready to
completely quit their addiction but are interested in harm reduction. Further, MET is a
proven effective treatment for reducing substance use, yet requires fewer sessions than
many standard therapies, therefore, potentially offering a reduction in operating costs and
an increase in the number of people who can be treated.
A criticism of MET is that recovery from addiction requires additional attention
beyond a realization of problem behaviors, values, and desire to change. Treatment of
physical illness and/or comorbid psychiatric disorders as well as teaching social and
coping skills and increasing problem solving capacity all may be required to achieve and
sustain recovery. Therefore MET can be included initially to engage clients into
treatment and then combined with other therapies that develop coping skills and manage
common risk situations that may lead to further drug use (Dunn, Deroo, & Rivara, 2001).
Hettema, Steele, and Miller (2005) found in a meta-analysis of 72 clinical trials
spanning a range of target behaviors that MET was an effective brief intervention
technique for drug using behaviors, though there was great variation in results across
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trials. Significant improvement in treatment outcomes with the addition of MET to a
standard treatment was hypothesized to be due to the increase in treatment retention and
adherence, especially when those were the specific targets of MET. In a population with
similar ages to the Job Corps trainees, Aubrey (1998) reported a doubling of outpatient
substance abuse treatment sessions attended by adolescents given a single session of
MET at intake, as well as a doubling of 3-month abstinence rates. In addition, MET was
found to be especially effective with ethnic minority populations (Hettema et al., 2005),
which suggests it may be effective with Job Corps trainees.
MET can be particularly effective in engaging difficult-to-treat adolescents in
therapy (Masterman & Kelly, 2003). MET allows adolescents to reflect upon their drug
use and possible negative consequences without direct confrontation by an adult
therapist, which then results in reduced resistance (Marlatt & Witkiewitz, 2002). The
brief nature of MET and limited required resources make it well suited for institutional
settings (Bien, Miller, & Boroughs, 1993; Brown & Miller, 1993) such as correctional
facilities, and MET also works well with individuals high in anger or hostility (Karno &
Longabaugh, 2004). In one study (Breslin, Li, Sdao-Jarvie, Tupker, & Ittig-Deland,
2002), four sessions of MET were found to help reduce drug use and drug-related
negative consequences while improving enthusiasm for additional treatment among
adolescents in an addiction treatment program. And, Stein et al. (2006) found that MET
significantly mitigated negative treatment engagement for incarcerated adolescents in
substance abuse group therapy.
The ease in which MET can be embraced, both by the provider and client, and
support from clinical studies suggest that MET has the potential to aid in the reduction of
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drug use for incoming trainees at Job Corps by increasing their motivation to more fully
engage in their substance abuse program. A more detailed review of the MET literature
related to marijuana and alcohol treatment, focusing on adolescents when possible, is
discussed in later sections.
Contingency management (CM).
CM uses the concepts of operant conditioning and behavioral economics to
encourage positive behavioral change. Desired behaviors are reinforced systematically in
a timely manner while undesired behaviors result in the withholding of reinforcement or
administration of punishment. The magnitude of reinforcement required to elicit change
in behavior depends on the elasticity of the behavior. In substance abuse treatment,
positive behaviors such as abstinence, medication compliance, and therapy attendance
can be reinforced using CM. The theory behind CM and how it can be implemented in
substance abuse treatment are discussed in more detail below.
Incentives are used throughout our culture to improve behavior in many aspects of
our lives—for example, employers give wages and bonuses based on performance,
teachers give high marks for well done assignments, parents give allowances for chores,
and governments may give tax breaks for the use of alternative energy sources. As
mentioned above, the Job Corps also offers many positive reinforcements for achieving
continued success in the program (e.g., housing, food, small monetary stipends). Operant
conditioning uses consequences to modify behavior by systematically reinforcing desired
behaviors and withholding reinforcement or administering punishment for undesired
behaviors. Drug abuse is a form of operant behavior in that drug use is reinforced by the
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biochemical effects on the body and by environmental influences such as social
reinforcement by peers (Higgins & Petry, 1999).
Animal research on self-administration of drugs has demonstrated that the laws of
learning and conditioning can be used to modify drug intake through reinforcement and
punishment (Higgins & Petry, 1999). Logan (1972) was instrumental in providing
evidence that animals respond to operant contingencies with psychoactive substances.
When made available, animals readily ingest and abuse most of the same substances as
humans (e.g., alcohol, cocaine, opioids) and exhibit the same patterns of drug dependence
(e.g., forego sustenance in order to engage in drug use, perform laborious tasks to attain a
supply of drugs) (Petry & Heyman, 1995). These early observations of drug abuse and
reinforcement led to new theories on substance abuse and treatment methods (Schuster &
Thompson, 1969).
Behavioral economics is the study of how behavior is influenced by economic
limitations and examines conditions that influence consumption of commodities,
including drugs of dependence (Bickel & Marsch, 2001). There are two fundamental
concepts related to drug dependence: elasticity of demand and discounting. Elasticity of
demand refers to the proportionate change of consumption in relation to the change in
price. If an individual decreases their drug use less than the proportionate increase in
price, then their behavior would be an inelastic consumption. Many drug addictions are
considered to be relatively inelastic. For example, spending money to satisfy a drug
addiction can supersede allocating funds for even basic needs such as food and housing.
With respect to substance abuse treatment, the demand curve for the drug also can be
used to determine the appropriate level of intervention required to reduce substance use.
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From an implementation perspective, a balance must be struck between minimizing
operational costs and creating effective incentives to encourage drug abstinence (Petry et
al., 2004).
Discounting refers to how delayed reinforcers are devalued compared to
immediate reinforcers. Discounting may account for the impulsivity or “loss of control”
of drug use where the immediate effects of the drugs are more important than the greater,
though delayed, pro-social rewards. For example, an individual may express a strong
interest in establishing a good family life or work history, but then choose to use drugs
and forego both of those desires for the immediate effects of the drugs (Bickel & Marsch,
2001).
The use of CM for treating drug use was first found to be effective in animal
studies, and subsequently found to be very effective with human subjects for treating
addictions and meeting other treatment goals (e.g. attendance, medication compliance,
and maintaining employment) (Higgins & Petry, 1999). One method of reinforcing
behavior is through the awarding of vouchers, cash-equivalent certificates used to
purchase mutually agreed upon items in support of a drug-free lifestyle. Adding CM to
empirically supported treatments for substance use dependence (e.g., community
reinforcement approach [CRA], cognitive behavioral therapy [CBT], and MET) has
improved both retention and abstinence rates during and after treatment in controlled
clinical trials for the treatment of alcohol, cocaine, marijuana, nicotine, and opioid
dependence (Higgins, Alessi, & Dantona, 2002). The first implementation of voucherbased reinforcement therapy in a controlled trial was used as a strategy to retain
outpatients in a cocaine treatment program and to promote initial abstinence (Higgins et

Eliciting Abstinence

12

al., 1991). CM studies also have used monetary awards that are contingent upon
abstinence or achieving predefined treatment goals (Sigmon, Steingard, Badger,
Anthony, & Higgins, 2000). However, cash-based CM is not a commonly used method
because it is criticized for “paying drug abusers to be abstinent” and for potentially
providing them with money to purchase additional drugs as well as for other reasons,
such as the cost, time to train staff to administer, etc.
An alternative model of voucher-based CM is that of the fishbowl method, first
designed and used by Petry, Martin, Cooney, & Kranzler (2000), which addresses the
concern of giving cash to substance abusers. Typically, draws from a prize bowl are
awarded for clean urine screens, and for each draw, there is the potential of immediately
winning a $1, $20 or $100 prize. Most cards say “Good luck, try again!” and the
probability of pulling a winning card is proportionate to its value (e.g., there is only one
$100 jumbo price card out of 500 cards). After each card is drawn, it is then reinserted
into the bowl to keep the probability of winning the same for each draw. Participants are
encouraged to request prizes that are rewarding to them in order to increase their
involvement and interest in the reward system.
Concerns regarding the efficacy of CM are based on several important issues
including: the need for targeting a particular drug, the lasting effects of CM once it has
been discontinued, and the need for proper implementation (Higgins & Petry, 1999). One
possible consideration is to view CM not as a substance abuse treatment in itself, but
rather as a tool that buys time to sample abstinence. And subsequently, this time allows
for an empirically supported treatment (EST) to have time to work, and it is through the
EST that the lasting effects of sobriety are enhanced. In addition, CM gives an incentive
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to the individual to sample abstinence with the hope that the lifestyle benefits of sobriety
may become intrinsically reinforcing.
An additional concern regarding CM and the fishbowl method is that while it has
the advantage of reducing the cost of CM, it has been criticized for inciting or
exacerbating gambling addictions. This concern was investigated and not found to be
supported (Petry, Alessi, Marx, Austin, & Tardiff, 2005); nevertheless, as a precautionary
measure, a common exclusion criterion is a current or past diagnosis of gambling
addiction.
A general criticism of all CM methods is the cost, which potentially can reach
nearly $1,000 per person (Higgins et al., 1994; Higgins, Badger, & Budney, 2000) though
on average participants earn considerably less than the potential maximum (e.g., in
Higgins et al.,1994, the average amount awarded was $601). In addition, significant time
is involved for staff to negotiate and purchase the items. Finally, there is a delay between
choosing to abstain from drug use and reporting this abstinence for reward; therefore the
participant is not immediately reinforced for their behavioral change.
In spite of the costs, CM can enhance therapies such as CBT or MET. In
addition, CM is effective with a variety of populations (dually diagnosed individuals,
homeless, veterans, juveniles, etc.) and for a variety of addictions (cocaine, heroin,
marijuana, alcohol, etc.). Finally, CM is effective in increasing retention in research
studies and therapy sessions (Higgins et al., 1994; Petry et al., 2005). In the current
study, it was surmised that individuals testing positive for drugs upon entering the Job
Corps would have some motivation to abstain from drug use in order to stay in the
program, however, any additional assistance in shaping their behavior and supporting this
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change would be beneficial. It was hypothesized that CM would provide additional time
that would allow for both the exploration of ambivalence regarding substance use and
greater awareness of the dissonance between values and drug using behaviors, thereby
increasing motivation to actively engage in the substance use program provided by Job
Corps.
Marijuana Studies
Marijuana is the most commonly used illicit drug in the United States with 14.6
million users in the past month (Substance Abuse and Mental Health Services
Administration; SAMHSA, 2005). Of those, 3.4 million use marijuana on a daily or
almost daily basis. In 2005, the rate of past-month marijuana use among youths ages 12
to 17 was 6.9%, while use among young adults ages 18 to 25 was 16.6%. Such
significant marijuana use constitutes an alarming statistic given the associated negative
consequences of drug use. Although controversial, studies have identified marijuana as a
gateway drug leading to the use of other illicit substances (Chen & Kandel, 1995; Kandel,
Yamaguchi, & Chen, 1992). Frequent marijuana use among adolescents is associated
with diminished educational and occupational opportunities, greater incidence of
health/psychiatric issues, and higher rates of criminal incarceration (Ellickson, Martino &
Collins, 2004; Windle & Wiesner, 2004).
Treatment programs for marijuana dependence have expanded dramatically in the
past two decades. However, the prevalence of young adults voluntarily seeking treatment
for chronic marijuana dependence is very low; treatment is more often a consequence of
involvement of school administration, family members, or the legal system (Deas &
Thomas, 2001; Szapocznik et al., 1988). Furthermore, marijuana users typically are less
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motivated to change their using behavior than those abusing other drugs and are more
likely to drop out of treatment programs (Budney, Radonovich, Higgins, & Wong, 1998;
Sinha, Easton, Renee-Aubin, & Carrol, 2003).
The efficacy of MET and CM was examined in the treatment of many habitual
marijuana users (see Table 1). Participants have varied in their demographics from those
seeking treatment for marijuana dependence, to adolescents following mandatory drug
treatment through the criminal justice system, to others with existing psychiatric
conditions not interested in changing their drug use. Most studies used a randomized,
controlled experimental design focused solely on marijuana use; while others
implemented within-subject controls, polydrug treatment, or allowed for existing
psychiatric issues. A brief description of the findings of the marijuana studies is
presented below, and a more critical review of the similarities and differences between
conclusions of both the marijuana and alcohol studies is discussed later in the text.
MET studies.
The literature is mixed regarding outcomes of studies that used MET as the sole
treatment of marijuana use. Several studies have demonstrated the efficacy of shortduration MET for improving marijuana abstinence and secondary effects of marijuana
abuse compared to delayed control or no treatment groups (Copeland, Swift, Roffman, &
Stephens, 2001; Marijuana Treatment Project Research Group, 2004; Martin &
Copeland, 2008; McCambridge & Strang, 2004; Stephens, Roffman, & Curtin, 2000).
However, other studies found no significant difference in marijuana outcome regardless
of treatment conditions (Dennis et al., 2004; Peterson, Baer, Wells, Ginzler, & Garrett,
2006; Walker, Roffman, Stephens, Berghuis, & Kim, 2006). In addition, the effect of
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treatment duration (i.e., number of MET sessions) was not found to be significant in
several marijuana studies (Copeland et al., 2001; Dennis et al., 2004; Stephens et al.,
2000), although more sessions yielded better outcomes in at least one study (Marijuana
Treatment Project Research Group, 2004).
CM studies.
Marijuana studies utilizing CM with an escalating scale of reinforcement resulted
in longer periods of continuous abstinence (Budney, Moore, Rocha, & Higgins, 2006;
Carroll et al., 2006; Kadden, Litt, Kabela-Cormier, & Petry, 2007; Sigmon & Higgins,
2006). And, long-term abstinence rates were improved when CBT was added to the CM
program (Budney et al., 2006; Carroll et al., 2006; Henggeler et al., 2006; Kadden et al.,
2007). CM also improved session attendance in marijuana studies when specifically
targeted for reinforcement (Carroll et al., 2006; Sinha et al., 2003). In addition, the rate
of posttreatment abstinence depended strongly on the initiation of abstinence early in the
treatment, which was enhanced by adding CM to the treatment program (Carroll et al.,
2006; Sigmon, Steingard, Badger, Anthony, & Higgins, 2000). However, changes in
secondary measures of drug use were not strongly influenced by adding CM (Budney et
al., 2006).
Combined MET and CM studies.
A few marijuana treatment studies have investigated the efficacy of both MET
and CM (Budney et al., 2000; Kadden et al., 2007; Lott & Jencius, 2009; Sinha et al.,
2003; Stagner, Budney, Kamon, & Thostensen, 2009). Studies that included both MET
and CM produced better outcomes, such as longer periods of continuous abstinence,
compared to MET alone (Budney, Higgins, Radonovich, & Novy, 2000; Kadden et al.
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2007; Stanger et al., 2009). However, changes in secondary measures of drug use were
not strongly influenced by adding MET to the treatment program (Budney et al., 2000;
Sinha, Easton, Renee-Aubin, & Carroll, 2003; Stanger et al., 2009).
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Marijuana Studies
Design

Possible Earnings

Positive
Outcome,
p ≤ .05

14

MET v. MET + CBT v. MET + CBT +
CM

$570

Y

90;
M= 69, F=21

14

CBT v. CM v. CBT + CM

$570

Y

Sinha et al., 2003

65
M=60, F=5

4

MET v. MET + CM

$120

Y

Carroll et al., 2006

136
M=121, F=15

8

MET + CBT v. MET + CBT + CM v.
DC (individual drug counseling) v. DC +
CM

$880.

Y

Henggeler et al., 2006

161
M=134, F=27

16

Family Court (FC) v. Drug Court (DC) v.
DC + Multisystemic Therapy (MST) v.
DC + MST + CM

Kadden et al., 2007

240;
M=170, F=70

9

MET + CBT v. CM v MET + CBT + CM
v. Case Management (CaseM)

$385

Y

Lott & Jencius, 2009

336;
M=231, F=105

12

MET + CBT v. MET + CBT + CM

$130

N

Sigmon et al., 2000

18;
M=18

25

Non-contingent CM—abstinence
contingent CM (CV1,CV2,CV3)—Noncontingent CM

$500 for Non-contingent CM
$250 (CV1), $500 (CV2),
$1,000 (CV3)

Y

Study

CM Marijuana Studies
Budney et al., 2000
Budney et al., 2006

N;
Gender

Duration
(weeks)

60;
M=50, F=10

Eliciting Abstinence

Table 1

Y
------

18

Marijuana Studies (continued)
Design

Possible Earnings

20

Non-contingent CM—abstinence
contingent CM—Non-contingent CM

$930

Positive
Outcome,
p ≤ .05
Y

14

MET + CBT v. MET + CBT + CM +
family management

$590

Y

229;
M=159, F=70

1 session MET + CBT v. 6-sessions MET
+ CBT v. DCT

N/A

Y

Dennis et al., 2004

600;
M=498, F=102

5 session MET+CBT v. Control

N/A

N

Marijuana Treatment
Project, 2004

450;
M=308, F=142

2-session MET v. 9-session
MET+CBT+Case Management v. DCT

N/A

Y

McCambridge & Strang,
2004

200;
M=92, F=108

1 session MET v. Control

N/A

Y

Martin & Copeland, 2008

40;
M=27, F=13

2 sessions MET vs DTC

N/A

Y

Peterson et al., 2006

285;
M=156, F-129

1 session MET v. Control

N/A

N

Stephens et al., 2000

291;
M=224, F=67

2-session MET v. 14-session CBT v 4month DCT

N/A

Y

Walker et al., 2006

97;
M=46, F=51

2-session MET v. DTC

N/A

N

Study
Sigmon & Higgins, 2006
Stanger et al., 2009

Non-CM Marijuana Studies
Copeland et al., 2001

N;
Gender

Duration
(weeks)

7;
M=6, F=1
69;
M=57; F=12
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Marijuana Studies (continued)

Note. N = sample size, all groups combined. Gender: M = male, F = female. MET = motivational enhancement therapy; CBT = cognitive behavioral therapy; CM = contingency
management; DCT = delayed control treatment group. Total possible earnings during CM = maximum monetary value that could be earned by the voucher condition. If more than
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one type of contingency (abstinence and activities) was used, total possible earnings for all contingencies are noted. If more than one contingent voucher (CV) schedule was used,
total possible earnings of all the schedules equals the amount shown unless otherwise noted. Assume immediate delivery of vouchers. A dash (------) represents insufficient
information.
Positive outcome = a significant change (p ≤ .05) was reported for the behavior targeted by the contingency management: Y = yes, N = no.
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Alcohol Studies
Alcohol is the most commonly used drug in the United States. In 2005 more than
one half of Americans aged 12 or older (51.8%, n=126 million) reported using alcohol in
the past month (SAMHSA, 2005). Of those, approximately 55 million (22.7%) reported
binge drinking at least once in the past month. Binge drinking was defined as five or
more drinks in the same occasion for men, and four or more for women. The rate of pastmonth alcohol use among youths increases with age: 12-13 (4.2%); 14-15 (15.1%); 16-17
(30.1%); 18-20 (51.1%); and 21-25 (67.4%). Rates of binge drinking peak at 49.9% of
21 year olds. Among older segments of the population the percentages of past-month
alcohol use decreases with age: 26-59 (63.7%); 60-64 (47.5%); 64 and older (40%).
Regular alcohol use is linked with brain damage (e.g., loss of coordination, poor
judgment, slowed reflexes, distorted vision, memory lapses, and blackouts), damage to
vital bodily organs, and cancers. Even infrequent use can affect self-control as alcohol
depresses the central nervous system, lowers inhibitions, and impairs judgment—which
can lead to risky behaviors such as use of other drugs, unprotected sex, violent
altercations, and driving while intoxicated. In large doses in a short period of time,
alcohol poisoning or motor accidents may result in immediate death.
Given these data, it is clear that alcohol dependence and abuse are most prevalent
among our younger population and are associated with many deleterious effects.
Treatment programs for alcohol dependence have expanded dramatically in the past 35
years. However, just as for those seeking treatment for marijuana, the prevalence of
young adults voluntarily seeking treatment for alcohol dependence is very low, and
among those who do, it is usually a result of external pressure. Furthermore, in some
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populations (e.g., trainees at the Job Corps) alcohol is thought to be used as a substitution
drug when attempting to decrease or abstain from use of other drugs, including
marijuana, and therefore needs to be monitored while providing treatment for the use of
other illicit drugs.
MET and CM studies were reviewed to examine the efficacy of these treatments
for alcohol use disorders (see Table 2). Due to the vast literature related to MET and
alcohol treatment, this review focuses only on those related to adolescents, as they were
the target population for the study. In contrast, the relative paucity of CM studies
focusing on alcohol necessitated including polydrug CM studies that focused mainly on
adult subjects. Brief descriptions of these findings are offered below, while a more
critical review of the similarities and differences between conclusions of both the
marijuana and alcohol studies is presented later in the text.
MET studies.
MET has its origins in the treatment of alcohol abuse utilizing motivational
interviewing (MI) techniques (Miller, 1983). Several meta-analyses have concluded that
MET is an effective method for treating alcohol problems in adults (Dunn et al., 2001;
Heather, 2005; Hettema et al., 2005; Noonan & Moyers, 1997). More specifically, MET
for alcohol treatment was found to be most effective for those who consumed large
amounts of alcohol and who were more ambivalent about changing their alcohol
consumption (Burke, Arkowitz, & Menchola, 2003; Project MATCH, 1997). However,
adolescents have a relatively short history of alcohol use compared to adults, fewer
alcohol-related negative consequences, and difficulty imaging that future goals and
drinking are incompatible, which may suggest that MET is not the ideal therapy for this
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demographic in the treatment of alcohol use (Tevyaw & Monti, 2004). Some studies
have found no significant reductions in alcohol-related problems post-MET for the
adolescent demographic (Baer et al., 1992; Larimer et al., 2001; Murphy et al., 2001).
Baer et al. (1992) attributed the significantly lower drinking rates across all study groups
to the social desirability of providing positive results to the researcher, possibly leading to
reporting bias. Murphy et al. (2001) attributed the lack of a significant treatment effect to
study design, but also to the lack of additional verification of self-reported drinking. And
finally, Larimer et al. (2001) reported that the brief intervention did not significantly
impact alcohol-related consequences and attributed that shortcoming to the measurement
tools and the contextual factors involved with drinking within a fraternity environment.
However, other studies reported that MET was an effective treatment method for
treating adolescents in reducing alcohol consumption (Borsari & Carey, 2000; Larimer et
al., 2001; Marlatt et al., 1998; Monti et al., 1999) and secondary measures of the impact
of alcohol abuse (Marlatt et al., 1998; Monti et al., 1999). In college-age adolescents,
brief interventions using MET significantly reduced the number of drinks consumed, the
frequency of drinking in general, and binge drinking in particular (Borsari & Carey,
2000). In first year fraternity members receiving MET treatment for alcohol abuse, total
average alcohol consumption was reduced and lower peak blood alcohol levels were
reported but there were no significant improvements in secondary measures of alcohol’s
impact on their lives (Larimer et al., 2001). In another study following students
transitioning from high school to college, MET was shown to be effective at reducing the
rate of drinking and the harmful consequences of alcohol use (Marlatt et al., 1998). And
finally, for adolescents involved in alcohol-related events resulting in emergency room
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treatment, a brief MET intervention resulted in lower incidences of driving under the
influence and alcohol-related problems (Monti et al., 1999).
CM studies.
While case studies and controlled trials conducted in the 1970’s offered initial
support for CM strategies as being effective for treating alcohol dependent patients
(Bigelow, Griffiths, & Liebson, 1975; Griffiths, Bigelow, & Liebson, 1978; Liebson,
Tommasello, & Bigelow, 1978; Miller, 1975; Miller, Hersen, Eisler, & Watt, 1974), there
is very little in the literature investigating this strategy with alcohol dependence from
1990-2007. After a thorough review of the literature, Petry et al. (2000) conducted the
only study found that was designed to specifically target alcohol dependent individuals
using CM. Eight additional polydrug studies meeting the criteria for this review (see
Table 2) indicated that at least 50% of their participants also reported alcohol abuse or
dependence. These polydrug studies were examined to identify potential secondary
effects of the treatment for alcohol dependent individuals.
CM with an escalating schedule of reinforcement resulted in longer periods of
continuous alcohol abstinence (Petry et al., 2000). When specifically targeted by
reinforcement, CM improved session attendance in alcohol treatment settings (Helmus,
2003; Petry et al., 2000). However, secondary measures of alcohol use did not
significantly differentiate between treatment methods (Carroll, Sinha, Nich, Babuscio, &
Rounsaville, 2002; Higgens et al. 1994, 2000; Petry et al., 2000, 2004, 2006).

Alcohol Studies

Study

CM Alcohol Voucher Based
Higgins et al., 1994.

N;
Gender;
% With
Alcohol
Disorder

Duration
(weeks)

Design

Possible Earnings or
Draws; Average Cost

Positive
Outcome
p ≤ .05

ASI (alcohol)
Change

40;
M=27, F=13;
55%

12

CRA v. CRA + abstinent
contingent reinforcement

$997.50

Y

Sig. decrease
in both groups
across time.

Higgins et al., 2000.

70;
M=51, F=19;
57%

24

CRA + abstinent contingent
reinforcement v. CRA + non
abstinent contingent
reinforcement

$997.50 for weeks 1-12
and $24 in lottery tickets
during weeks 13-24

Y

Sig. decrease
in both groups
across time.

Downey et al., 2000.

41;
M=25, F=16;
68.3%

12

ST + CM, abstinence v. ST +
CM, non-contingent (yoked
control).

N

Carroll et al., 2002.

46;
M=36, F=19;
50.9%

12

Naltrexone (n) + low-mag
vouchers v. n + high-mag
vouchers

Slight decrease
for contingent
CM in weeks 1
& 17, but not
for 5.
Sig. decrease
in both CM
groups across
time.

Helmus et al., 2003.

20;
M=15, F=5;
70%

20

A (4-week baseline)- B (12week CM treatment- A (4week return to baseline)

------

Low: $561
High: $1,152

------

Y

Y
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N/A

avg. cost $31.5 ±13.9
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Alcohol Studies (continued)

Study

CM Voucher Based Fishbowl Alcohol Studies
Petry et al., 2000.

N;
Gender;
% With
Alcohol
Disorder

Duration
(weeks)

Design

Possible Earnings or
Draws; Average Cost

Positive
Outcome
p ≤ .05

ASI (alcohol)
Change

42;
M=42;
100%

8

ST v. ST + CM

128 draws

Y

Sig. decrease
in both CM
groups across
time.

Petry et al., 2004.

120;
M=53, F=67;
60%

12

ST v. ST + CM, $80 v. ST +
CM, $240

Low, $80
High, $240

Y

Sig. decrease
in both CM
groups across
time.

Petry et al., 2005.

142;
M=65, F=77;
50%

12

ST v. ST + vouchers (STV)
v. ST + prizes (STP)

Vouchers: $882.

Y

No reported
decline over
time.

131;
M=79, F=52;
63%

12

Y

Sig. decrease
in both CM
groups across
time.

Petry et al., 2006.

Prizes: 575 draws.
ST v. ST + CM, abstinence
v. ST + CM, activities

291 draws, abstinence
group
294 draws, activities
group
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Alcohol Studies (continued)

Study

N;
Gender;
% With
Alcohol
Disorder

Duration
(weeks)

Design

Possible Earnings or
Draws; Average Cost

Positive
Outcome
p ≤ .05

ASI (alcohol)
Change

6-week class v. 6-unit selfhelp manual v. 1-hr feedback
and advice session

N/A

Y

N/A
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Non-CM Alcohol Studies
132;
M=63, F=69

1-6

60;
M=26, F=34

1

No treatment control v. 1
session MI

N/A

Y

N/A

159;
M=159, F=0

1

No treatment control v. 1
session MI

N/A

Y

N/A

348;
M=160, F=188

1

No treatment control v. 1
session MI, plus feedback

N/A

Y

N/A

94;
M=64, F=36

1

Standard care v. Brief 1
session MI

N/A

Y

N/A

84
M=39, F=45

1

1 session MI v. 1 session
education

N/A

Y

N/A

Baer et al., 1992
Borsari & Carey, 2000
Larimer et al., 2001
Marlatt et al., 1998

Monti et al., 1999
Murphy et al., 2001
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Alcohol Studies (continued)

Note. N = sample size, all groups combined. Gender: M = male, F = female. % of alcohol disorder = % of total number randomized into study. CRA = community reinforcement
approach; MI = motivational interviewing; CM = contingency management. ASI = Addiction Severity Index. Total possible earnings during CM = maximum monetary value that
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could be earned by the voucher condition. If more than one type of contingency (abstinence and activities) was used, total possible earnings for all contingencies are noted. If
more than one contingent voucher (CV) schedule was used, total possible earnings of all the schedules equals the amount shown unless otherwise noted. Assume immediate
delivery of vouchers. A dash (------) represents insufficient information.
Positive outcome = a significant change (p ≤ .05) was reported for the behavior targeted by the contingency management: Y = yes, N = no.
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Conclusions and Trends
MET: conducive to adolescents and young adults.
In spite of some research findings, MET seems inherently well suited for the
adolescent and young adult substance abusing population. MET’s brief duration, nonconfrontational and empathetic therapist style, and emphasis on clarifying life goals and
exploring the incompatibility of substance use may be more palatable than other types of
therapy, given adolescents’ often limited financial resources, unwillingness to be in
treatment, and lack of trust in authority. Treatment is necessary for this population since
they tend to have higher rates of binge drinking in combination with marijuana use,
truancy and school problems, and employment difficulties, and MET may encourage
these young adults to seek further treatment for their substance use.
MET: reduced substance abuse.
Brief interventions involving MET were shown to be effective for reducing
marijuana use (Copeland et al., 2001; Marijuana Treatment Project Research Group,
2004; McCambridge & Strang, 2004; Stephens et al., 2000) and alcohol abuse (Dunn et
al., 2001; Heather, 2005; Hettema et al., 2005; Noonan & Moyers, 1997). Focusing
specifically on adolescents, MET was effective in reducing marijuana use (McCambridge
& Strang, 2004) and alcohol consumption (Borsari & Carey, 2000; Larimer et al., 2001;
Marlatt et al., 1998; Monti et al., 1999).
MET: secondary measures.
Secondary measures of marijuana abuse, such as psychological stress over the use
of marijuana and marijuana-related problems, were improved in some MET versus
control group studies (Copeland et al., 2001; Marijuana Treatment Project Research
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Group, 2004; McCambridge & Strang, 2004; Stephens et al., 2000). However, in others,
there were no significant reductions in alcohol-related problems after MET for
adolescents (Larimer et al., 2001; Murphy et al., 2001).
CM: abstinence rates.
Combining CM with an EST, especially with an escalating schedule of
reinforcement, resulted in longer periods of continuous abstinence in many marijuana
studies (Budney et al., 2000, 2006; Carroll et al., 2006; Kadden et al., 2007; Sigmon &
Higgins, 2006) and in the one published alcohol study (Petry et al., 2000). Prior cocaine
studies have demonstrated that CM alone engenders greater abstinence during treatment
than CBT alone (Epstein, Hawkins, Covi, Umbricht, & Preston, 2003; Rawson et al.,
2002). These studies support the assertion that CM programs with an escalating schedule
of positive reinforcement are effective at increasing the duration of continuous
abstinence. These long periods of continuous abstinence are thought to be important for
long-term outcomes because they allow time to establish alternative sources of non-drug
reinforcement (Budney et al., 2006; Carroll et al., 2006). In addition, CM alone or CM
added to another treatment resulted in a higher total number of days abstinent in some
marijuana studies (Carroll et al., 2006; Kadden et al., 2007; Sigmon & Higgins, 2006),
thereby allowing for other positive reinforcers to be experienced.
CM: initiation of early abstinence.
Initiating abstinence early in treatment was found to be an important factor in
determining rates of abstinence post-treatment in some marijuana studies (Carroll et al.,
2006; Sigmon et al., 2000). These results are significant because the submission of an
initially marijuana-free urine sample is a strong indicator of treatment outcome (Moore &
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Budney, 2002), and because stable periods of abstinence are associated with better longterm functioning (Higgins et al., 2000).
CM: treatment attendance.
Voucher-based rewards can target specific behaviors besides abstinence, as shown
previously for increased methadone treatment attendance and medication compliance
(Carroll et al., 2001; Iguchi et al., 1996; Preston et al., 1999). And, CM can improve
session attendance in marijuana (Carroll et al., 2006; Sinha et al., 2003) and alcohol
treatment settings (Helmus, 2003; Petry et al., 2000). These results are also in accord
with prior cocaine CM studies targeting attendance (Higgins et al., 1994; Silverman et al.,
1996). Improving session attendance via CM is an especially important target for
engaging apathetic young adults in treatment (Deas & Thomas, 2001; Santisteban et al.,
1996; Sinha et al., 2003). Notably, in Budney et al. (2000) the relatively low retention
rate for the MET+CBT+CM group (when compared to similar cocaine CM studies) was
attributed to three potential issues: (1) lack of a CRA component in the study, which acts
as reinforcement for attending treatment, (2) smaller voucher amounts, and (3) lower
intrinsic motivation to change.
CM: long-term abstinence.
Adding CBT to another therapy treatment, especially CM, results in better longterm abstinence (Budney et al., 2006; Carroll et al., 2006; Henggeler et al., 2006; Kadden
et al., 2007). These results are in accord with prior cocaine studies, which found that
CBT+CM produced better long-term abstinence (Epstein et al., 2003; Rawson et al.,
2006). In addition, cocaine CM studies demonstrated a strong correlation between long
periods of abstinence during treatment (3-4 weeks) and long-term (2 year) post-treatment
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abstinence (Higgins et al., 2000). These results suggest that CBT is important for
maintaining the initial abstinence effect of vouchers, and that the coping skills from CBT
may prevent relapse and aid in the maintenance of abstinence (Budney et al., 2006).
However, the relatively low rate of long-term abstinence in the Kadden et al.
(2007) study was attributed to the comparatively low budget ($385/person maximum).
According to prior studies, the relationship between the value of CM and the
effectiveness of the intervention varied: increasing the magnitude of reinforcement was
associated with more positive outcomes in some studies (Lussier, Heil, Mongeon,
Badger, & Higgins, 2006); however, using lower value vouchers was still effective in
another (Petry et al., 2004); while some found no difference in high- versus low-value
voucher magnitudes (Carroll et al., 2002; Sigmon et al., 2000).
CM: secondary measures.
Secondary measures of drug use, such as the Addiction Severity Index (ASI), did
not usually differentiate between treatment methods in the marijuana studies (Budney et
al., 2000; Budney et al., 2006; Sinha et al., 2003) or the alcohol study (Petry et al., 2000).
For the alcohol polydrug studies, the ASI Alcohol scores decreased over time but there
were no differences between treatment groups (Carroll et al., 2002; Higgens et al., 1994,
2000; Petry et al., 2004, 2006). This finding may suggest that perhaps any and all
intervention improves psychosocial functioning. The only strong exception to this trend
of no difference between treatment groups was the Carroll et al. (2006) marijuana study,
which demonstrated that the CM group showed marked improvement in ASI composite
scores compared to the non-CM groups.
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Similar trends were observed in marijuana studies using CM in populations with
mental illness (Sigmon et al., 2000; Sigmon & Higgins, 2006) and polydrug users
(Henggeler et al., 2006). It was suggested that in polydrug studies, a differential drug use
comparison over time should be included because drug substitution may occur in which
reduction in the use of the targeted drug can be superseded by increased use of other
drugs (Shaner et al, 1997).
Future Directions
Participants.
The Job Corps represents a specific subset of alcohol and marijuana abusers and
therefore special consideration should be taken when applying the previously stated
findings to studies with this population. For example, Sinha et al. (2003) noted that
probation-referred marijuana users may not represent all young users, and that the
compulsory treatment program may yield a different outcome compared to treatment for
those seeking help voluntarily. And in Budney et al. (2006), the authors pointed out that
their study was composed mostly of white males from a university-area, however, they
went on to state that their results might extend to a more ethnically-diverse metropolitan
demographic, however, this was an area in need of further study. Thus, introducing CM
and MET to the substance abuse program at Job Corps would provide information on the
efficacy of MET and CM for improving outcomes for this difficult to reach ethnically
diverse, population of alcohol and marijuana abusing young adults.
Controlling the expense of CM.
CM is a valuable tool in the treatment of substance use disorders; however, it is
still not widely applied in clinical settings. One of the major limitations and criticisms of
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implementing CM in community settings is the expense. Beginning in 2000, Petry et al.
dramatically reduced costs of the commonly used voucher and cash system from
approximately $1,000 per individual to $200 by using the fishbowl technique.
Nevertheless, for many organizations, paying even $200 per person is unmanageable,
even though initiating and perhaps sustaining abstinence makes this cost to society low in
comparison to that of continued drug use and treatment.
Petry et al. (2004) investigated the effects of lowering the reinforcement
magnitude by increasing the percentage of non-winning cards and decreasing the number
of draws. However, they found that the higher magnitude group ($240) was more
effective than the lower magnitude group ($80) in achieving abstinence. Therefore, most
studies have reverted back to the original fishbowl design. Nevertheless, something else
needs to be done with this style of CM to make it more appealing and affordable while
still keeping the methodology simple, and two suggestions are offered below.
To understand how the financial component of the fishbowl method may be
improved upon, an analysis of the expected payout for each award must be determined.
A common fishbowl design (Petry et al., 2006) is to have 500 cards with 275 (55.0%)
cards stating ‘Good job, try again’, 199 (39.8%) awarding small prizes ($1), 25 cards
(5.0%) awarding large prizes ($20), and 1 (0.2%) representing a jumbo prize ($100).
Based upon this distribution of card values, the expected payout for each value type can
be evaluated. The expected payout per draw for the $1 cards is $1*(199/500) = $0.398
per draw, $20 cards is $20*(25/500) = $1.00 per draw, and $100*(1/500) = $0.20 per
draw for a total expected payout for this system of $1.598 per draw. If an individual
earns 100 draws throughout the course of the study, the actual expected cost would be
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about $160. The $20 cards represent the highest component of the total payout for this
distribution of cards. Therefore, one simple method of controlling the cost was to reduce
the number of $20 cards; however, the psychological impact of the reward system was
diminished with this simple change (Petry et al., 2004). Instead, the reward system itself
can be modified to potentially enhance the psychological impact while continuing to
decrease the cost.
The CM method used in the present study was of original design. In this system,
poker chips are used and participants win a prize for matching two consecutive colored
chips out of a bag. For each award, participants draw twice and attempt to match any of
three colors: two white chips represented a $1 prize; 2 blue chips a $20 prize; and 2 red
chips a $100 prize. If two chips of different colors are drawn, the individual does not win
anything. After each completed draw the participant returns the chips to the bag to
ensure consistent probability. This study used a chip bag containing 500 chips in which
405 (81%) were white, 75 (15%) were blue, and 20 (4%) were red. The expected payout
per award (where an award constitutes drawing two chips) for this system was computed
by the following equation:

2

2

2

 405 
 75 
 20 
Expected Payout Per Award  
 $1  
 $20  
 $100  $1.27
 500 
 500 
 500 

Therefore, the expected payout per award is $1.27, 20% lower than the $1.598 payout for
the standard fishbowl method. This method also improves on the negative psychological
effect of possibly drawing a card that makes one an "instant loser".
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Marijuana as a drug of abuse.
Evidence of physical dependence on cannabis is suggested by reference to the
terminology “marijuana withdrawal syndrome,” which implies that bodily functions are
altered and undesirable symptoms are associated with removal of the drug (Budney et al.,
2001). However, the withdrawal symptoms are relatively mild compared to drugs such
as cocaine or methamphetamines and increased marijuana use to avoid withdrawal is
atypical (Julien, 2005, pg. 575). As a consequence, many users have the perception that
marijuana does not have any serious consequences on their lives because it is a “soft”
drug incapable of causing an “addiction” (Julien, 2005).
This perception of the safety of marijuana may in part explain poor attendance
and retention rates in therapy for those entering compulsory treatment and may be related
to lower motivation to change drug using behavior. Psychotherapy is normally a
component of treatment, but rather than address the actual marijuana abuse, it often
focuses on underlying psychopathologies such as depression that can result from the
abuse of marijuana (Julien, 2005). Rather than focusing on the ancillary conditions that
may precede marijuana use, such as an episode of depression, this literature review
supports the use of therapies such as MET (Budney et al., 2000; Carrol et al., 2006;
Kadden et al., 2007; Sinha et al., 2003) that encourage an understanding of one’s values
and bring forth an awareness of the incompatibility of drug use behaviors. Besides the
impact on one’s health, marijuana use can result in lower employability due to candidatescreening via drug testing, legal problems due to possession or paraphernalia charges, and
conflict with friends and family. Upon guided self assessment, many of these secondary
impacts of marijuana use may become more obvious to the individual, and if so may
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outweigh their perception of it being a “soft” drug. Consequently, the user may decide to
modify their drug using behavior on their own or enter a substance abuse treatment
program.
As previously noted, many studies examined MET as a treatment method for
marijuana abuse or dependence. However, for a therapist to help a client achieve a
critical state of awareness, most individuals require more than one session with a
therapist to build the necessary trust and rapport to facilitate this process. And since CM
was used successfully to improve treatment attendance, combining MET and CM
together was expected to enhance the ST effectiveness.
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Purpose of the Study

There is support in the literature for MET as an acceptable therapy for achieving
abstinence and increasing retention, and for CM being a useful tool in enhancing both of
these objectives when combined with various ESTs including MET. However, it is
unclear if CM combined with MET statistically improves treatment retention and number
of days not using substances over and above ST for Job Corps students.
Therefore, the primary purposes of this study were to investigate whether the
addition of MET and CM to the Job Corps’ ST package significantly increased retention
rates and therapy attendance, and decreased use for incoming trainees who tested positive
for marijuana during their initial drug screen. The main hypotheses were that trainees
receiving MET+CM+ST would demonstrate statistically significantly higher rates of
therapy attendance, retention, and number of days not using marijuana than ST alone. In
addition, it was hypothesized that the ST group would do better than the non-randomized
participant sample in therapy attendance, retention, and number of days not using
marijuana.
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Method

This research was approved by all required parties at the Job Corps, including the
Regional and National Director of the Job Corps and the Department of Labor, as a pilot
study for the treatment of substance use of new enrollees. This study also was approved
after a full review by the Institutional Review Board for Research with Human Subjects
(IRB), University of New Mexico (UNM), Albuquerque, New Mexico. In addition, after
receiving approval from the IRB at UNM, an application to the National Institutes of
Health for a Federal Certificate of Confidentiality (FCC) was made before recruiting
participants and an FCC was received. This certificate is designed to protect the privacy
of vulnerable research study participants and allows researchers to refuse disclosure of
any identifiable sensitive information at the federal, state, and local level by any civil,
criminal, or administrative proceedings. All researchers and therapists completed the
required IRB certification training for research with human subjects. Support in the form
of drug screens and office space was provided by the Albuquerque Center Job Corps,
Wellness Center.
Participants
Participants were fourteen (N=14) young people (ages 16-25) enrolled in the
Albuquerque Center Job Corps who failed their initial drug screen, and who were
randomly assigned to one of two groups: ST with 4 sessions of MET and CM
(MET+CM+ST), or ST alone (ST).
Individuals were eligible for recruitment into the study if they were able to give
informed consent and (1) tested positive for marijuana within the first 24 hours of being
at the Center (“initial drug screen”) (N=14), or (2) had disclosed a known marijuana
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and/or alcohol use problem in the past 90 days either verbally on their pre-screen for
application into the Job Corps and or through self-referred into the TEAP program within
the first 7 days (N=0). Individuals testing positive for other drugs in addition to
marijuana were still eligible for the study. Trainees meeting these criteria were assessed
to determine further interest and eligibility for the study by the TEAP counselor.
Trainees were ineligible to participate if they were unable to fully comprehend
every element of the study and were therefore unable to give informed consent (N=0);
had an active psychotic condition (e.g., schizophrenia or bipolar) not currently controlled
for with medication as determined by the screening questions from modules of a
structured clinical interview designed to assess psychological distress (N=1); admitted to
previous difficulties with gambling (N=0); or were unable or unwilling to obtain their
parent’s or guardian’s written permission to participate if under the age of 18 and did not
meet the criteria for emancipation used to qualify for the Job Corps (N=2). A resident
was considered emancipated “according to applicable laws of the state; or is under 18
years of age and married, and thereby considered to be emancipated; or has no parent or
legal guardian; or has been unsuccessful, with the assistance of the AC [Job Corps’
recruiters], in locating a parent or guardian” (PRH, Exhibit 1-1, page 11).
Demographic data for the Albuquerque Center (N=429, as of January 8, 2008)
included 58.28% (n=250) men and 41.72% (n=179) women with 89.98% (n=386)
residents of New Mexico. The ethnic representation included 51.75% (n=222) Native
American or Alaskan Native; 35.20% (n=151) Hispanic or Latino; 9.79% (n=42)
Caucasian or White; 2.56% (n=11) Black or African American; 0.47% Asian (n=2); and,
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0.23% (n=1) other. In addition, 21.21% (n=91) were ages 16 or 17, and 78.79% (n=338)
were 18 years or older.
Study participants versus non-randomized participants.
Of the seventeen (N=17) individuals approached to be in the study, 14 (82.35%)
consented to the study and 13 (92.86%) of those completed the initial, 4-week, and 3month assessments. One (7.14%) individual in the treatment group completed the initial
assessment, attended three MET sessions, and was dismissed from the Job Corps due to
excessive absences in his fifth week of training, and no further data were obtained,
including his 4-week assessment. However, this individual passed his official drug retest for Job Corps prior to being dismissed from the program.
Of the remaining three individuals who were approached to be in the study, two
were minors who refused to get their parents’ permission to be in the study and one who
was ineligible due to active, untreated psychotic symptoms. In addition, 19 individuals
who tested positive for marijuana upon entry into Job Corps were not able to be
approached for the study due to time delays caused by a two-week summer break at Job
Corps (n=8, 42.11%), UNM’s IRB study suspension (n=6, 31.58%) related to an internal
audit that resulted in all studies with vulnerable populations being suspended temporarily,
and a Job Corps’ study suspension (n=5, 26.32%) because of a temporary lack of direct
therapy supervision on the Job Corps campus. These (N=22) individuals who were not
enrolled in the study but who tested positive for ThC upon entry into the Job Corps,
retrospectively became the “non-randomized participant control group” for comparison
purposes to those who were randomized into the study.
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Procedure
Once the individual expressed interest in the study, the TEAP counselor arranged
a meeting with the principal investigator (“researcher”) and the trainee. The researcher
briefly described the study and informed those interested in participating of their potential
time commitment: an initial 2 hour pre-assessment; a potential 4 week treatment period,
consisting of one psychotherapy session each week lasting up to 50 minutes; weekly
urine samples; and a post-treatment and 3-month follow-up, lasting approximately 1 hour
each (see Appendix A). The researcher conducted a screening to determine eligibility for
the study, and this screen contained a brief description of the study (see Appendix B).
Screening questions from modules in the Structured Clinical Interview for DSM-IV
(SCID; First, Spitzer, Gibbon, & Williams, 1995, see Appendix C) were used to assess
drug use diagnoses as well as potential psychosis.
Once interest and eligibility were determined, the researcher provided a thorough
explanation of the study, re-confirmed the person’s interest in participation, offered an
opportunity to ask any questions or express any concerns, highlighted the main points of
the informed consent, offered an additional opportunity to ask questions or express
concerns and then ensured the informed consent was signed and witnessed (see Appendix
D). If an individual was under the age of 18 and not considered emancipated by New
Mexico State Law (thereby a “minor”), a parent or guardian consent was required. For
those minors, a meeting was arranged and the parent or guardian was fully informed
regarding the study by the researcher. If they agreed to consent their child into the study,
they signed the informed consent document for their minor to participate in this research
(see Appendix E). The minor was then fully informed and their assent was obtained (see
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Appendix F); their assent represented an affirmative agreement to participate in this
research study. Every effort was made to ensure that the participants, and if necessary,
parents/guardians, understood each element of the study.
The TEAP counselor acted as an advocate for the participants and reassured them
that absolutely no negative consequence would occur if they decided not to participate in
this research project. After the researcher fully described the study, and before receiving
signatures, the TEAP counselor met privately with the individuals to answer any
questions or address any concerns. If they continued to express interest, the required
signatures were obtained, and a copy of the consent and/or assent form was given to each
individual. The HIPAA authorization form was reviewed and signed by each trainee and
if necessary, the parents/guardians if they were minors (see Appendix G).
Next, demographic questionnaires were used to collect basic data (see Appendix
H). In addition, they were asked to provide a minimum of two contacts that could be
reached in the event they left the Job Corps before study completion (3 months from the
day of entry into the study) (see Appendix I). Participants were made aware that these
individuals would be contacted in an attempt to locate them for the sole purposes of
obtaining follow-up study data for Weeks 4 and 12. They also were informed of the
exact wording that would be used in contacting these individuals and assured that no
additional information would be shared.
The participants were then given a numerical ID that was used on all additional
questionnaires and drug screen results, and this information was kept in the assigned
therapist’s office at the Mental Health Center in a locked file cabinet. The namenumerical ID slips were stored in a locked cabinet separate from all other forms. Slips
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were pre-made with assigned numbers and were assigned sequentially to each participant
(see Appendix J).
The brief screens, demographics, locator forms, and informed consents were kept
together in a separate locked file cabinet. Participants were informed that no records
identifying them by name were stored in the same room as any data involving drug use
and urine sample results; that identifiable drug using information would not be shared
with individuals outside of the research project, nor would it be shared with the TEAP
counselor. They were told that all identifying information would be kept in a separate
locked cabinet, and all questionnaires and drug test results (slips only, no actual samples)
would contain their study ID number and those results would be kept in their therapists’
locked file cabinet in a separate office. In addition, they were told that absolutely nothing
drug-related they submitted or disclosed in this research project could or would be used
against them (e.g., given to either the Health Center or the Director of the Job Corp and
consequently forcing them to exit the program due to a second positive urinalysis), and
that no one at Job Corps would have access to any of their information at any given point
in time, and that the researcher was not authorized to disclose trainees’ drug using
behaviors to others without their written permission.
Next, a urine sample was collected by the researcher (see Appendix K), followed
by three assessments. A Timeline Follow-back interview was used to collect information
on frequency of use of illicit drugs and alcohol in the past 3 months (Form 90-DI;
Tonigan, Miller, & Brown, 1997) (see Appendix L). The Stages of Change Readiness
and Treatment Eagerness Scale (SOCRATES; Miller & Tonigan, 1996) scale for both
alcohol and drugs was used to measure readiness to change drug use and alcohol
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behaviors, and was used subsequently to initiate discussion regarding motivation to
change in the first MET session (see Appendix M). The Addiction Severity Index Lite
(ASI; McLellan et al., 1992) was administered to assess substance use and secondary
effects associated with drug use, and that was used as the main measure of secondary
drug use outcomes (see Appendix N). These questionnaires were chosen to assess the
degree to which substances were being used, current level of functioning, consequences
of use, and motivation to change.
Subsequently, the participants were assigned to either MET+CM+ST or ST.
Originally, participants were randomly assigned via urn randomization to balance on the
following variables: gender, ethnicity, total months of addiction(s), and therapist.
However, due to unexpected time constraints for Therapist #1, they were randomized by
gender, ethnicity, and total months of addiction (first seven participants) but not therapist.
Then, due to unexpected time limitations on the study, the second seven participants were
alternatively assigned to either the control group or treatment group to ensure equal
representation for both groups. This resulted in seven (n=7) participants in
MET+CM+ST and seven (n=7) in ST. Therapy sessions were administered by two
master’s level clinical psychology graduate students.
After completion of all assessments, participants were scheduled to return within
seven days, for either their first MET session or their next meeting with the researcher.
The rules for the CM portion of the study were explained, and they were given an
attendance card to monitor ST therapy attendance (see Appendix O). The approximate
time for the pre-assessment was 90 minutes. Breaks, snacks, and sodas were offered
during this period.
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Treatment Conditions
MET plus CM plus ST.
Seven (n = 7) young adults were assigned to receive MET+CM+ST.
Standard treatment (ST).
Job Corps' standard treatment for individuals testing positive for drugs during
their initial screen required participation in TEAP. This program included (1)
assessment, (2) intervention, (3) counseling, (4) relapse prevention, and (5) prevention
and education. Individuals were required to sign a contract stating they would attend
three group therapy sessions per week (AA/NA Facilitation; Relapse Prevention; Drug
and Alcohol Prevention) for two weeks, and afterwards attend weekly individual therapy
(relapse prevention focused) until they tested negative on their second official urine
screen. If the trainees were in the program due to alcohol problems, they also were
required to attend six AA meetings held in the community. In addition, everyone was
required to participate in an exercise program for one hour per week and complete eight
hours of community service. This program was administered by a licensed drug
counselor.
Motivational Enhancement Therapy (MET)
All participants in the MET+CM+ST treatment condition were offered four
sessions of MET provided by a master’s level clinical psychology graduate student.
Training for MET was provided by a trainer from the Motivational Interviewing Network
of Trainers (MINT) who specialized in adolescents and substance abuse. William Miller,
Ph.D., the co-founder of motivational interviewing, was available for additional
supervision and guidance throughout the study.
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Four therapy sessions were conducted in a manner similar to the structure used to
treat young marijuana probationers in Sinha et al. (2003). Motivational interviewing
encourages clinicians to use an empathetic therapeutic style, avoid resistance and
argumentation, resolve ambivalence, heighten discrepancies about personal goals and
current behaviors (substance use), and elicit motivation to change (Miller & Rollnick,
2002). The first session was focused primarily on building rapport, listening to their
description of their drug use, providing information and feedback regarding the effects of
marijuana on their lives and bodies and discussing their motivation to change their
substance use behaviors (per SOCRATES responses). Motivation to participate in
therapy was heightened by highlighting the negative impact of drug use on their lives.
The second and third sessions were focused on an in-depth look into their values using
either a values card sort or by having a discussion regarding their values, and identifying
the discrepancies between their values and drug using behaviors (see Appendices P-R).
In addition, their motivational level was assessed and a change plan was discussed and
agreed upon. Alternatives to using substances and ways to avoid high-risk situations
were discussed. The fourth session reviewed the change plan, assessed high-risk
situations that had occurred during the past week, and elicited strategies for coping with
these situations, cravings, and slips. After completion of the four MET sessions, a
recommendation to continue contact with the TEAP specialist was made to facilitate
continued abstinence.
Contingency Management (CM)
At each session, participants in the MET+CM+ST condition reviewed their
attendance record for both ST and MET for the previous week, and submitted urine
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samples. Marijuana abstinence and successful attendance for all therapy (MET and ST)
were reinforced in the MET+CM+ST group.
During the first session, the rules of the CM program were explained and
participants were given the opportunity to ask questions and make recommendations for
prizes. In order to introduce the participants to CM and give them exposure to the
rewards associated with being successful, they were awarded the full amount of draws
(n=15) possible for abstinence, attendance, and the bonus available for the first week,
regardless of their behaviors. In addition to giving them an opportunity to sample the
rewards associated with success, this design also helped to address the issue of marijuana
being a fat soluble drug and staying in the system for approximately three weeks. The
first sample in which they were reinforced for abstinence based on their urine samples
occurred in Week 2 of the study, which meant the participants had been at Job Corps for
longer than three weeks, and therefore the original marijuana in their system should have
been no longer detectable had they been abstinent since entering Job Corps.
After each MET session, the therapist totaled the number of draws earned, gave
the participants the opportunity to draw from the chip bag, and an appointment was
scheduled for the following week. Attendance for the ST group and individual therapy
was determined based on a signature card signed by the ST counselor, and the ST
counselor was consulted to verify attendance when the card was not available.
After each MET session, participants assigned to the MET+CM+ST group were
given opportunities to draw chips from a bag based on their previous week’s behaviors.
Each week they demonstrated attendance compliance for both MET and ST, and
submitted negative screens for marijuana they earned 5 bonus awards, and the number of
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awards for attendance and abstinence escalated by 2 for each week of successful
completion. If they missed any of their therapy sessions or submitted a positive drug test,
the number of awards was reset to 5 in each category, and no bonus was awarded for that
week. As previously mentioned, to whet their interest and because marijuana is a fat
soluble drug, after the first session, they were treated as if they were successful with both
their attendance and abstinence and were given 15 awards (5 for attendance, 5 for
abstinence, and 5 for the bonus). Participants had the opportunity to earn up to 32 awards
for attendance, 32 awards for abstinence, and 20 for bonuses, for a total of 84 awards (see
Table 3).
Table 3
CM Award Schedule for MET+CM+ST Group
100% successful—abstinence and activities.
Abstinence Attendance Bonus
Total
Week 1:

5

5

5

15 (guaranteed)

Week 2:

7

7

5

19

Week 3:

9

9

5

23

Week 4:

11

11

5

27

Total

32

32

20

84

Note. MET = motivational enhancement therapy; CM = contingency management; and
ST=standard treatment.

For each award, participants drew twice and attempted to match colors: two white
chips represented a $1 prize; 2 blue chips a $20 prize; and 2 red chips a $100 prize. If
two chips of different colors were drawn the individual did not win anything. After each
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completed award of two draws, the participant returned the chips to the therapist, who
dropped them back into the chip bag to ensure consistent probability and to guard against
cheating.
This study used a bag containing 500 chips in which 405 (81%) were white, 75
(15%) were blue, and 20 (4%) were red. The expected payout per award (where an
award constitutes the drawing of two chips for matching purposes) for this system was
computed by the following equation:

2

2

2

 405 
 75 
 20 
Expected Payout Per Award  
 $1  
 $20  
 $100  $1.27
 500 
 500 
 500 

With an expected payout per award of $1.27 and a potential of 84 possible awards, the
maximum expected payout per individual was $106.68. The informed consent document
educated the participants of the probabilities for each of the groups, and the expected
payout per draw.
Participants requested the opportunity to “bank” their prize money to put towards
larger prizes in the future. This was an unexpected and welcomed change to the design
as it demonstrated ability to delay reinforcement, a skill to be encouraged in a substanceusing population, and also provided some insurance that the participants would come
back the following week. Prizes were purchased by the researcher and kept on-site in
locked cabinets. Examples of prizes that were awarded in this study included: $100—
Ipod nanos, digital cameras, and portable DVD players; $20—basketballs, footballs,
backpacks, DVDs, jewelry, and diapers; and $1—Gatorade, candy, cookies, and fast food
gift certificates.
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Advantages of this system over the typical fishbowl system (Petry et al., 2000,
2004, 2006) for administering CM included: a 21% decrease in the cost of administering
the program; a psychological advantage based on not having 55% of cards that were
instant losers and instead having a 32% chance of drawing a non-winning combination
and a 68% of winning something, albeit with more $1 prizes and less $20 prizes; and, an
increased opportunity to be connected with a larger prize initially, as the chance of
pulling a blue ($20) chip on the first draw was 15% compared to only 5% for the
traditional fishbowl system and the chance of pulling a red ($100) chip on the first draw
was 4% compared to only 0.5% for the fishbowl system. This connection with a large or
jumbo prize was more likely to be present initially, and this increased connection may
have instilled a greater sense of being close to winning the larger prizes. However, upon
the second draw the likelihood of actually winning the bigger prizes was lower than the
fishbowl method (blue: 2.25% versus 5.0%; red, 0.16% versus 0.2%), thereby decreasing
the cost of this program but potentially increasing the excitement associated with the
process. Psychologically, pulling a card that says ‘Nice job, try again’ may leave one
with an immediate feeling of loss, and perhaps even a sense of failure. However, with
this chip system, the feeling of having ‘two’ chances to pull the right combination may
have increased anticipation and hope, if only for an additional moment.
Standard Treatment (ST)
Seven (n=7) young adults were assigned to the ST only condition. The ST was
mandatory for all trainees who failed their first official drug test. Urine samples and
attendance cards for ST were collected weekly by the researcher, and missing cards were
verified via a consult with the TEAP counselor. Regardless of substance use or therapy
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attendance individuals were given five chances to win prizes simply for meeting with the
researcher and submitting these data.
The maximum award for those in the ST group was 20 awards (see Table 4), and
the maximum expected payout per individual was $25.40.
Table 4
CM Award Schedule for ST
100% successful—submitting both drug screens and attendance card.
Drug Screen & Attendance Card
Total
Week 1:
5
5
Week 2:
5
5
Week 3:
5
5
Week 4:
5
5
Total

20

20

Note. CM = contingency management; and ST=standard treatment.
Study Duration
Due to the mandatory re-test policy toward the end of the probation period, active
participation in the study was four weeks in duration for each individual. Post-treatment
follow-up assessments and urinalyses were administered three months after treatment
entry. In order to entice individuals to submit the 3 month follow-up assessment, all
participants were given 20 awards from the chip bag for completing the assessment. The
duration for the study in its entirety was 24 weeks.
Therapy Session Recordings
All therapy sessions were recorded and 50% were randomly coded by a trained,
graduate level coder to ensure treatment integrity. The sessions were coded using the
motivational interviewing treatment integrity 3.0 (MITI 3.0; Moyers, Martin, Manuel,
Miller, & Ernst, 2007). In addition, these tapes were available during the study to address
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any concerns the therapists had regarding either the delivery of the treatment according to
protocol or the well-being of the individual. In the case of a clinical concern by the
graduate level therapist, the director of the UNM Psychological Clinic was notified and
involved in addressing that concern.
Clinical Meetings
Therapists met regularly to discuss any issues or concerns regarding individual
cases. The objectives of these meetings were to identify clinical concerns and help
ensure consistent treatment delivery. These meetings provided a format to address any
difficulties administering MET or CM to individuals, and to offer additional training.
William Miller, Ph.D. and the MINT trainer were available via telephone when concerns
arose regarding MET.
Clinical Emergencies and Supervision
In the case of a clinical emergency, the director of the Psychology Clinic at UNM
was available for consultation. The dissertation chair, Barbara McCrady, Ph.D., and the
Institutional Review Board for Human Subjects at University of New Mexico were to be
notified of any and all adverse events, but there were no adverse event in need of
reporting.
Drug Testing
Each individual was required to submit six urine samples (Weeks 0, 1, 2, 3, 4, &
12) and these samples were analyzed for ThC, methamphetimes, and cocaine. Only ThC
(the marker for marijuana use) was used for study purposes. Urine was randomly tested
to ensure validity of the sample by testing for temperature. If a sample failed the validity
check, it was to be discarded, and the participant was to be asked to submit another
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sample or have their original sample considered positive for marijuana; however no urine
samples failed due to temperature. Participants were immediately notified of their
results. The therapist was instructed to warmly respond and either offer congratulations
to the participant when testing negative or offer encouragement to the individual when
testing positive. Samples not submitted were treated as being positive for marijuana.
Destruction of Urine Samples
All drug screens were conducted in a building and bathroom separate from that of
the Wellness Center (the health center on campus), and no information or results were
given to any individual at the Wellness Center. All urine samples were poured into and
flushed down a toilet immediately after reading the results (no lab involved), the cups
then were rinsed with water, and disposed of in the appropriate trash receptacle. The
cups were unmarked and contained no identifiable information.
Follow-Up Assessment
After Week 4 of the study, follow-up assessments were scheduled. The following
assessments were conducted: Form 90 (Tonigan et al., 1997), ASI (McLellan et al.,
1992), and SOCRATES (Miller & Tonigan, 1996), and a urine samples were collected.
In addition, a 3-month post-entry, follow-up assessment was administered for each
individual enrolled in the study and consisted of the same measures as listed above. For
those individuals no longer affiliated with Job Corps, attempts were made to contact them
via information on their locator form by the researcher and, when possible, assessments
were scheduled.
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Measures
The Structured Clinical Interview for DSM-IV-R (SCID-II).
Two modules of the SCID-II (First et al., 1995), Section B—Psychotic and
Associated Symptoms and Section E—Substance Use Disorders, were used as criterion
measures to identify trainees who had active psychotic symptoms that prevented them
from consenting into the study, and to determine substance abuse and/or dependence.
The SCID-II is a widely used structured interview instrument that was developed to
provide accurate DSM-IV diagnoses. The abbreviated clinical version of the SCID-II
was used in this study. The SCID-II Psychotic and Associated Symptoms module was
used to identify active symptoms, and the Substance Use Disorders module was used to
identify lifetime and past 30-day diagnoses for alcohol and seven other drugs, including
marijuana. The SCID-II also differentiates between substance abuse and dependence
disorders. Clinical judgment was used to determine whether symptoms were present to
meet a disorder. Both modules required administration by a trained clinician and took
approximately 10 minutes to administer.
Test-retest reliability of the SCID-II was examined by Williams et al. (1992) in a
multisite study that included both clinical and nonclinical settings. Across clinical sites,
kappas for current diagnoses ranged from .40 to .86, with a median of .59. The range of
kappas was moderately high for both alcohol abuse/dependence (current diagnosis, .48.73; lifetime diagnosis, .64-.87) and drug abuse/dependence (current diagnosis, .63-.84;
lifetime diagnosis, .73-.83). Agreement for alcohol abuse and dependence diagnoses
varied considerably across sites. Inter-rater reliability of the SCID-II was consistently
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high for a range of disorders. Psychometric data specifically for Module B, Psychotic
and Associated Symptoms could not be found in the literature.
Form 90.
The primary assessment measure for substance use was a modified Form 90 DI
(Drug Intake) and Form 90 DF (Drug Follow-Up) (Tonigan et al., 1997). The Form 90 is
a structured assessment interview for drinking and related behaviors. Form 90 DI has
excellent test-retest reliability for indices of drug use in major categories (r ≥ 0.90 for 57
of 81 comparisons; Tonigan et al., 1997). This instrument uses a timeline follow-back
interview procedure to reconstruct daily substance use and was found to have good
reliability (r ≥ 0.77 for cocaine, opiates, and marijuana) and validity (Westerberg,
Tonigan, & Miller, 1998). In addition to substance use, this instrument also yields the
total number and type of drugs used, age of first use, level of use, as well as school and
work attendance, and living arrangements. During their weekly MET sessions,
participants were asked to report any substance using episodes on a weekly basis (what
drugs, frequency, and amount) and the results were recorded and kept on file to help
reconstruct the Week 4, Form 90 assessments. The Form 90 was used for the initial
assessment, and 1- and 3-month follow-ups.
Addiction Severity Index (ASI) Lite.
The Addiction Severity Index (ASI) is a structured interview that was used to
assess substance use and secondary effects associated with drug use (McLellan et al.,
1992). Seven areas are covered: medical status, employment status, alcohol use, drug
use, legal status, family/social relationships, and psychological status. The seven ASI
composite scores range from 0 to 1, with higher scores indicating more severe problems.
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The ASI Lite version is becoming more widely adopted because of the practicality of a
shorter questionnaire. The ASI Lite was used to collect general personal and
demographic information, along with medical status, employment/support data,
alcohol/drug use, legal status, family/social relationship information, and psychiatric
status. The ASI Lite contains 22 fewer questions than the ASI, and omits items related to
severity ratings. The internal consistency of the ASI Lite version (0.59 <  < 0.89) is
similar to the full version of the ASI (0.61 <  < 0.89) and demonstrates good reliability
(Cacciola, Alterman, McLellan, Lin, & Lynch, 2007). The ASI Lite was used for the
initial assessment, and 1- and 3-month follow-ups.
The Stages of Change Readiness and Treatment Eagerness Scale
(SOCRATES)
The Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES;
Miller & Tonigan, 1996) is a measure of readiness to change substance abuse behaviors
and displays good reliability for Ambivalence (r = 0.83), Recognition (0.94), and Taking
Steps (0.91). Two forms were given to assess alcohol use (SOCRATES 7A) and drug
use (SOCRATES 7D). Maisto, Chung, Cornelius, & Martin (2003) found support for a
14-item, two-factor structure of the SOCRATES for alcohol based upon a clinical sample
of adolescents. Excellent internal consistency was found for the 7-item Taking Steps
factor (= 0.93) and the 7-item Recognition factor (= 0.88) that reflects an individual’s
awareness of his or her alcohol problem.
The three factors that serve as subscales to identify readiness to change are the
Recognition, Ambivalence and the Taking Steps subscales. The Recognition subscale
represents the extent to which the participant acknowledges experiencing a problem
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related to their substance use and perceives that harm will come if they do not change
their behavior. The Ambivalence subscale represents the degree to which participants
have conflicting emotions about the pros and cons of their substance use. The Taking
Steps subscale represents the extent to which participants are actively engaged in
changing their substance using behaviors. The SOCRATES was used for the initial
assessment, and 1- and 3-month follow-ups.
Outcome Measures
Two primary dependent variables were considered for analysis: Job Corps’
retention and number of days abstinent. Retention was defined as the percentage of
trainees who passed their second official urine screen and were retained in the Job Corps
program. Total number of days abstinent was the sum of days the participant did not
consume alcohol or smoke marijuana as evidenced by both urine test and self-report.
Given the persistence of marijuana in the system for up to three weeks after last use for
chronic users, self report was relied upon for the first three weeks of entry into Job Corps
and the urine screen was relied upon for their fourth week and beyond.
Analyses
Subjects were initially randomly and then alternatively assigned to either ST or
MET+CM+ST. Differences between the two groups were examined by calculating the
covariance between groups for gender, ethnicity, total months of addiction and therapist.
Descriptive statistics (mean and standard deviation) were calculated for the
demographic data and initial scores for various values from the Form-90, ASI, and
SOCRATES questionnaires. Retention rates between groups were compared using a
two-tailed t-test for means.
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The dependent variable of interest, days abstinent, was analyzed using ANOVA
to contrast outcomes between the treatment and control group, and repeated measures
ANOVA was done to compare outcomes over time within treatment group. In addition
to abstinence, the data from the self-report instruments (Form 90, ASI, and SOCRATES)
were analyzed using ANOVA to compare between-group scores and repeated ANOVA to
test for time effects within a treatment group. However, due to the small sample size, the
results of the ANOVAs are not reported in the results section of this study.
Correlations between treatment outcomes and self-report scores were analyzed
within each treatment group. Finally, because marijuana and alcohol were concurrent
target drugs, the abstinence rates for the two drugs were compared to determine if they
were positively or negatively correlated. The correlation analyses did not add any
additional findings above and beyond the t-tests and are not included in the results section
of the study.
For all independent-samples t tests, Levene’s tests were used to evaluate the
assumption that the population variances for the two groups were equal. For those tests
that were significant for the equality of variance assumption being violated, the corrected
independent-samples t tests for unequal variances were used. For all analyses, the alpha
level was set at .05. Due to sample size, alpha values were not corrected for multiple
comparisons. Statistical analyses were conducted using SPSS version 14.0.
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Results

Intake
Demographics.
The original study sample (N=14) was comprised of 10 males and 4 females with
a mean age of 19.3 (SD = 2.58) (see Table 5). The ethnicity of this sample included: 7
American Indians; 3 Hispanics; 3 Caucasians; and 1 “other.” Participants completed an
average of 10.3 (SD = 2.35) years of education. Eleven trainees lived on the Job Corp
campus while 3 lived off-campus. The demographic characteristics are included in Table
5 and are similar to the general population at the Albuquerque Job Corps Center.
Table 5
Demographic Characteristics of Randomized Participants (N=14)
Treatment Group
MET+CM+ST (n=7)

Characteristic

Control Group
ST (n=7)

Total (N=14)

Demographic
Age, mean (SD)

18.71

(2.36)

19.86

(2.85)

19.3

(2.58)

Male, percent (N)

71.43

(5)

71.43

(5)

71.4

(10)

Female, percent (N)

28.57

(2)

28.57

(2)

28.5

(4)

American Indian

42.86

(3)

57.14

(4)

50.0

(7)

Hispanic

28.57

(2)

14.29

(1)

21.43

(3)

Caucasian

14.29

(1)

28.57

(2)

21.43

(3)

Other

14.29

(1)

0.00

(0)

7.14

(1)

Resident, percent (N)

85.71

(6)

71.43

(5)

78.57

(11)

Education, mean (SD)

10.71

(1.29)

9.07

(2.96)

10.3

(2.35)

Ethnicity, percent (N)

Note. MET = motivational enhancement therapy; CM = contingency management; and ST = standard treatment. N =
total number in sample. n = number in subsample. SD = standard deviation.

Substance use.
Approximately 78.57% (n =11) of the sample met criteria for a primary diagnosis
of marijuana dependence. The remaining 21.43% (n =3) met diagnostic criteria for
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polysubstance dependence, not including tobacco dependence. In the 90 days prior to
intake, all of the participants had used cannabis; 50.0% (n =7) used alcohol; 7.14% (n =1)
used cocaine; 7.14% (n =1) used amphetamines; and, 85.71% (n =12) used tobacco (see
Table 6 for details). The average number of substances used per using day at intake was
1.25 (SD = .35), and did not differ significantly between the treatment (M = 1.35, SD =
.42) and control (M = 1.15, SD = .27) groups, t(12) = 1.061, ns (see Table 7 for details).

Table 6
Substances Used in the Previous 90 Days—Intake (N=14)
Measure

Treatment Group
MET+CM+ST (n=7)
Percent
(N)

Control Group
ST (n=7)
Percent
(N)

Total (N=14)
Percent

(N)

THC Only

28.6

(2)

42.9

(3)

35.7

(5)

THC & Alcohol

42.9

(3)

42.9

(3)

42.9

(6)

THC & Hallucinogen

14.3

(1)

0

(0)

7.1

(1)

THC, Cocaine & Amphetamines

14.3

(1)

0

(0)

7.1

(1)

0

(0)

14.3

(1)

7.1

(1)

100

(7)

100

(7)

100

(14)

THC, Opioids & Alcohol
Total

Note. MET = motivational enhancement therapy; CM = contingency management; and ST = standard treatment. ThC
= Tetrahydrocannabinol/marijuana. N = total number in sample. n = number in subsample. SD = standard deviation.
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Table 7
Intake Measures Comparisons by Study Group (N=14)
Treatment Group
MET+CM+ST (n=7)
Mean
(SD)

Control Group
ST (n=7)
Mean
(SD)

PDA, marijuana

69.32

(29.27)

31.14

(30.75)

t(12) = 2.38, p = .04*

PDA, alcohol

96.61

(5.73)

99.20

(0.85)

t(6.29) = -1.53, p = .17

Joints smoked per using day

4.46

(2.88)

4.39

(2.17)

t(12) = .052, p = .96

Standard drinks per using day

5.67

(6.49)

2.91

(3.61)

t(12) = .98, p = .35

ASI, ThC composite***

0.06

(0.05)

0.16

(0.11)

t(12) = -2.07, p = .06

ASI, Alcohol composite***

0.03

(0.03)

0.02

(0.02)

t(12) = .32, p = .76

Recognition

51.43

(3.78)

55.71

(11.34)

t(12) = -0.95, p = .36

Ambivalence

34.29

(31.01)

24.29

(13.97)

t(12) = 0.78, p = .45

Taking Steps

58.57

(27.95)

37.14

(22.89)

t(12) = 1.57, p = .14

Measure

Comparison Tests

SOCRATES, drug scale

Note. ASI = Addiction Severity Index. SOCRATES = Stages of Change Readiness and Treatment Eagerness Scale.
MET = motivational enhancement therapy; CM = contingency management; and ST = standard treatment. PDA =
percent days abstinent. ThC = Tetrahydrocannabinol/marijuana. N = total number in sample. n = number in subsample.
SD = standard deviation.
* p < .05
** p < .01
*** ASI Composite scores range from 0 to 1; higher scores indicate greater severity.

Group equivalence.
Univariate tests (t-test or chi-square) were conducted on the demographic and
main substance use variables at intake. The MET+CM+ST and the ST group did not
differ significantly in age, education, gender, ethnicity, residence, number of weeks of
lifetime use of marijuana, or number of weeks of lifetime use of alcohol. Significant
differences were found in the number of lifetime weeks of tobacco use, with the ST group
having smoked significantly more weeks than the MET+CM+ST group.
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Independent-samples t tests were conducted to evaluate the differences between
percent days abstinent (PDA) for marijuana and number of joints smoked per using day at
intake for the both groups. The test was significant for PDA for marijuana use, with the
ST group using on more days than the MET+CM+ST group. However, the number of
joints smoked per using day did not differ significantly between the groups.
Independent-samples t tests were conducted to evaluate the differences between
PDA for alcohol and for number of standard drinks per using day at intake for the both
groups. The groups did not differ significantly on PDA for alcohol use or the number of
standard drinks per using day.
Independent-samples t tests were conducted to evaluate differences between
groups on all subscales of the ASI at intake, and none were found to be significant. The
marijuana composite and alcohol composite did not differ significantly between groups.
Participants in the MET+CM+ST group and the ST group reported similar levels of life
difficulties associated with marijuana and with alcohol.
Independent-samples t tests were conducted to evaluate differences between
groups on three SOCRATES subscores—Recognition, Ambivalence, and Taking
Action—for drug use between groups, and none were found to be significant.
SOCRATES results for alcohol use were not computed due to the high number (n=12) of
subjects who reported very low alcohol use.
Within Treatment Behavior
Attendance and rewards.
The attendance rate, measured as the percentage of ST sessions attended by the
participants, was not significantly different between the MET+CM+ST and ST groups
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(see Table 8). Eight was the maximum number of ST sessions available. The potential
for earnings and the number of awards earned and dollar value of winning draws were
significantly higher for the MET+CM+ST group than the ST group (see Table 8). The
maximum number of potential awards for the treatment group was 84, earned by
attending all MET sessions and passing the study drug screens for weeks 2, 3, and 4. For
the ST group, the maximum number of awards was 20; these were earned if they met
with the researcher weekly and submitted the urine tests. Assuming the expected payout
per award was $1.27 as outlined in the study proposal, the maximum expected payout
was $106.68 for the MET+CM+ST group if all 84 awards were earned, more than the
actual average payout of $85.85. For the ST group, the maximum expected payout was
$25.40 if all 20 awards for attendance were earned, and the actual average payout was
$18.71.
Table 8
Attendance and Reward Measures, Comparisons by Study Group (N=14)
Treatment Group
MET+CM+ST (n=7)
Mean
(SD)

Control Group
ST (n=7)
Mean
(SD)

ST Treatment Sessions Attended (%)

89.74

(12.99)

78.27

(25.78)

Number of Awards Earned

57.71

(26.80)

16.43

(5.56)

t (6.52) = 3.99, p = .00**

Dollar value of winning draws ($)

85.85

(48.64)

18.71

(9.18)

t (6.43) = 3.59, p = .01**

Measure

Comparison Tests

t (11) = 1.05, p = .31

Note. MET = motivational enhancement therapy; CM = contingency management; and ST = standard treatment. N =
total number in sample. n = number in subsample. SD = standard deviation.
* p < .05
** p < .01
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Differences between therapists.
There was a significant difference between MET-consistent responses between
therapists, t(14) = 4.83, p < .001, with Therapist #1 having an average of 88.46%
(SD=2.87) MET-consistent responses and Therapist #2 having a mean of 82.61%
(SD=1.82) MET-consistent responses. However, no therapist effect for retention was
found, as all participants in the MET+CM+ST group were retained by Job Corps.
Further, no therapist differences were found for the participant’s Week 4 study urine
screens, χ2(1, N=7) = .058, ns, or for the 3-month follow-up urine screens, χ2(1, N=7) =
1.22, ns.
Week 4 Outcomes
Urine drug screen.
Five of the seven participants in the ST group passed the final Job Corp drug
screen; each of those five were granted extensions. Seven participants in the treatment
group passed the final Job Corp drug screen and one person received an extension.
Weekly extensions were offered by the TEAP counselor if the participants acknowledged
they were likely to fail their official drug screen which would result in being expelled
from Job Corp.
A two-way contingency table analysis was conducted to evaluate whether study
participants in the MET+CM+ST group were more likely to pass their Week 4 study
urine screen than those in the ST group. The two variables were study group with two
levels (MET+CM+ST group and ST group) and results of Week 4 study urine test with
two levels (failed or passed). The study group (MET + CM + ST or ST alone) and results
of the Week 4 drug test were significantly related (see Table 9) with the MET+CM+ST
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group passing the urine tests significantly more than the ST group. However, because the
groups differed significantly in PDA for marijuana at intake (see Table 7), a logistic
regression was conducted to control for the effect of PDA on treatment outcomes (see
Table 10). In this regression model, the treatment condition did not significantly change
the model fit compared to a model based on initial PDA for marijuana, χ2(1, N = 14) =
1.269, ns. Due to small sample size, individual coefficients in the regression model were
not interpretable (Greenland, Schwartzbaum, & Finkle, 2000).
In a logistic regression model predicting Week 4 urine test results based on
treatment condition and Week 4 PDA for marijuana, the addition of treatment condition
to the model significantly improved model fit above prediction based on PDA alone,
χ2 (1, N= 14) = 10.385, p < .01. Again, individual coefficients in the regression model
were not interpretable due to small sample size (Greenland et al., 2000).
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Table 9
Week 4 Outcome Measures, Comparisons by Study Group (N=14)
Measure

Treatment Group
MET+CM+ST (n=7)
Mean
(SD)

Control Group
ST (n=7)
Mean
(SD)

Comparison Tests

100.0

n/a

71.4

n/a

2(1, N=14)= 2.23, p = .13

71.0

n/a

0.0

n/a

2(1, N=14)= 7.78, p = .01**

PDA, marijuana

96.42

(4.63)

72.95

(36.70)

t(6.22) = 1.68, p = .14

PDA, alcohol

86.76

(25.50)

95.67

(7.85)

t(11) = -.883, p = .40

Joints smoked per using day

0.94

(1.16)

3.07

(2.71)

t(11) = -1.78, p = .10

Standard drinks per using day

3.12

(3.60)

4.08

(5.44)

t(11) = -.368, p = .72

ASI, ThC composite***

0.03

(0.05)

0.11

(0.15)

t(7.28) = -1.26, p = .25

ASI, Alcohol composite***

0.05

(0.11)

0.02

(0.02)

t(11) = .82, p = .43

Recognition

46.67

(5.16)

51.43

(9.00)

t(11) = -1.14, p = .28

Ambivalence

31.67

(19.41)

22.86

(11.13)

t(11) = 1.03, p = .33

Taking Steps

61.67

(26.39)

35.71

(19.88)

t(11) = 2.02, p = .07

Pass Job Corps’ final drug screen (%)
Pass Week 4 study drug screen (%)

SOCRATES, drug scale

Note. ASI = Addiction Severity Index. SOCRATES = Stages of Change Readiness and Treatment Eagerness Scale.
MET = motivational enhancement therapy; CM = contingency management; and ST = standard treatment. PDA =
percent days abstinent. ThC = Tetrahydrocannabinol/marijuana. N = total number in sample. n = number in subsample.
SD = standard deviation.
* p < .05
** p < .01
*** ASI Composite scores range from 0 to 1; higher scores indicate greater severity.
** p < .01
*** ASI Composite scores range from 0 to 1; higher scores indicate greater severity.
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Table 10
Fit Coefficients for Logistic Regression Models Predicting Week 4 Urine Tests
χ2

Blocks
Predicting Week 4 Urine Tests, Week 1 PDA
Week 1, PDA for ThC Only
Week 1, PDA + Treatment Group

19.039
17.770

Predicting Week 4 Urine Tests, Week 4 PDA
Week 4, PDA for ThC Only
Week 4, PDA + Treatment Group

6.938
17.323

Note. χ2 = computed value of chi square test. PDA = percent days abstinent. Treatment
group = MET (motivational enhancement therapy) + CM (contingency management) +
ST (standard treatment). ThC = Tetrahydrocannabinol/marijuana.

Additional independent-samples t tests were conducted to identify significant
differences between those individuals who passed their Week 4 study drug test (n=5) and
those who failed (n=9). A t test for PDA for marijuana at intake, t(11.73) = -4.79, p = .00
found that participants who failed the Week 4 drug test (M = 31.46, SD = 28.30) reported
significantly fewer days abstinent in the past 90 days at intake than those who passed the
Week 4 drug test (M = 84.02, SD = 12.54). Also, there was a significant difference in
reported lifetime days of use of tobacco t(12) = 3.98, p = .00 between those who failed
the Week 4 drug test (M = 291.78, SD = 143.46) and those who passed (M = 25.60, SD =
44.32).
PDA–marijuana and alcohol.
The mean PDA for marijuana and alcohol at Week 4 did not differ significantly
between the MET+CM+ST and ST groups.
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ASI scores.
The ASI composite scores at Week 4 comparing the MET+CM+ST group to the
ST group were not found to be significant for either the drug or marijuana scores.
SOCRATES drug scores.
Independent-samples t tests were conducted to test for significant differences
between groups for three subscales of the SOCRATES regarding drug use. None of the
SOCRATES drug score subscales at Week 4 were found to be significant when
comparing study groups; however, differences approached significance, p=.07, for the
Taking Steps subscale, with the MET+CM+ST group tending to report more behavioral
changes than the ST group.
3-Month Outcomes
Urine drug screen.
All seven participants in the ST group either failed the drug test or admitted to
marijuana use at the 3-month follow-up. Three participants in the MET+CM+ST group
submitted negative drug tests, one participant was not reachable and was assumed to have
failed, and the remaining three failed by either providing a positive drug test or by
admitting to drug use that would have resulted in a positive test.
A chi-square test was conducted to evaluate differences in the urine tests pass-fail
for marijuana at the 3-month follow-up comparing the MET+CM+ST group relative to
the ST group (see Table 11). The chi-square probability was significant, with
participants in the MET+CM+ST group on the average having a greater pass rate than the
ST group.
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Table 11
3-Month Follow-Up Outcome Measures, Comparisons by Treatment Group (N=14)
Measure

Pass 3-month follow-up drug screen (%)

Treatment Group
MET+CM+ST (n=7)
Mean
(SD)

Control Group
ST (n=7)
Mean
(SD)

Comparison Tests
χ2(1, N=14) = 3.82, p = .05*

42.9

n/a

0.0

n/a

PDA, ThC

87.83

(20.67)

46.29

(44.40)

t(8.75) = 2.21, p = .055

PDA, alcohol

82.67

(28.59)

97.50

(3.55)

t(5.13) = -1.26, p = .26

Joints smoked per using day

2.25

(2.64)

4.64

(3.11)

t(11) = -1.50, p = .16

Standard drinks per using day

1.62

(3.41)

4.07

(5.57)

t(11) = -.94, p = .37

ASI, ThC composite***

0.05

(0.06)

0.22

(0.02)

t(11) = -2.91, p = .01**

ASI, Alcohol composite***

0.09

(0.15)

0.02

(0.02)

t(5.12) = 1.29, p = .25

Recognition

51.67

(4.08)

52.86

(7.56)

t(11) = -0.34, p = .74

Ambivalence

28.33

(16.02)

22.86

(13.80)

t(11) = 0.66, p = .52

Taking Steps

66.67

(25.03)

31.43

(17.73)

t(11) = 2.97, p = .01**

SOCRATES, drug scale

Note. ASI = Addiction Severity Index. SOCRATES = Stages of Change Readiness and Treatment Eagerness Scale.
MET = motivational enhancement therapy; CM = contingency management; and ST = standard treatment. PDA =
percent days abstinent. ThC = Tetrahydrocannabinol/marijuana. N = total number in sample. n = number in subsample.
SD = standard deviation.
* dp < .05
** p < .01
*** ASI Composite scores range from 0 to 1; higher scores indicate greater severity.
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PDA for marijuana.
An independent-samples t test was conducted to compare PDA for marijuana for
the MET+CM+ST group versus the ST group. The test approached significance, p =
.055, with participants in the MET+CM+ST group having greater PDA for marijuana
than the ST group at the 3-month follow-up.
PDA for alcohol.
Independent-samples t test were conducted to compare the MET+CM+ST group
to the ST group for PDA and for standard drinks per using day at intake and at the 3month follow-up. No significant differences were found between the MET+CM+ST and
the ST groups with respect to PDA for alcohol, and the t- test for the standard drinks per
using day indicated similar drinking in both groups.
In addition, regarding total lifetime weeks of alcohol use, the independentsamples t- test found no significant difference between groups, t(12) = .46, ns, with the
participants in the MET+CM+ST group (M = 115.86, SD = 187.40) drinking similarly to
the ST group (M = 81.00, SD = 76.82).
ASI for marijuana.
An independent-samples t- test was conducted to evaluate differences in
composite ASI score for marijuana at the 3-month follow-up in the MET+CM+ST group
relative to the ST group. The test was significant with participants in the MET+CM+ST
group on the average having lower marijuana composite scores than the ST group.
SOCRATES drug scores.
Independent-samples t- tests were conducted to identify significant differences
between groups for the three subscales of the SOCRATES regarding drug use. Only the
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Taking Steps scale for the 3-month follow-up was found to be significant with the
MET+CM+ST group reporting greater endorsement of Taking Steps than the ST group.
Differences related to week 4 urine screen.
Additional independent-samples t- tests were conducted to identify significant
differences in 3-month outcomes between those individuals who passed their Week 4
study drug test (n=5) and those who failed (n=9). At the 3-month follow-up there was a
significant difference in PDA for marijuana, t(7.51) = -3.35, p = .01, reported between
those who failed the Week 4 drug test (M = 46.41, SD = 41.11) and those who passed (M
= 95.95, SD = 6.27). An additional t- test found that the composite drug score, t(8.19) =
4.25, p = .00, was significantly different for those who failed their Week 4 drug test (M =
.05, SD = .03) than those who passed (M = .01, SD = .01). In addition, the composite
marijuana score was significantly different, t(8.17) = 4.21, p = .00, for those who failed
their Week 4 drug test (M = .21, SD = .12) than those who passed (M = .02, SD = .03).
Study participants versus non-randomized participants.
The non-randomized participant sample (N=22) was comprised of 17 males and 5
females with a mean age of 18.36 (SD = 1.81). The ethnicity of this sample included: 10
American Indians, 9 Hispanics, 2 African Americans, and 1 Caucasian. There were no
significant differences in demographics between those who consented into the study
(N=14) and those who were not in the study (N=22) in relation to: gender, χ2 (1, N=36) =
.01, ns; age, t(34) = -1.26, ns; or ethnicity, χ2(4, N=36) = 6.05, ns.
A two-way contingency table analysis was conducted to evaluate whether trainees
in the MET+CM+ST group, ST group, and those not consented into the study were
retained equally at Job Corps. The two variables were treatment condition with three
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levels (MET+CM+ST, ST, or not consented) and results of final mandatory drug test with
two levels (failed or passed). The group they were in and results of the final mandatory
drug test trended towards significance, χ2(2, N=36) = 5.03, p = .08. This suggested a
movement towards significant differences between groups, with the Job Corps retaining
100.00% of the MET+CM+ST group; 71.43% for the ST; and 54.55% for the nonrandomized participant control group.
Additional analyses were conducted to compare retention rates after the
probationary period at Job Corps for those who entered the study and those who were not
consented into the study, but who were eligible based on testing positive for marijuana on
their initial drug screens. A two-way contingency table analysis was conducted to
evaluate whether trainees were more likely to be retained by Job Corps if they were
consented into the study versus not being consented into the study. The two variables
were study status with two levels (enrolled in the study or not consented into the study)
and results of final mandatory drug test with two levels (failed or passed). Study status
and results of final mandatory drug test were significantly related, χ2(1, N=36) = 3.74, p =
.05. The proportions of trainees who were retained included: 85.71% for study
participants (100.00% for the MET+CM+ST group; 71.43% for the ST group); and,
54.55% for those not enrolled in the study.
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Discussion

The primary purpose of this study was to investigate whether the addition of MET
and CM to the Job Corps’ ST package significantly impacted retention rates, therapy
attendance, and substance use for incoming trainees who tested positive during their
initial drug screen compared to ST alone. The main hypotheses of the study were that
trainees receiving MET+CM+ST would demonstrate (a) statistically significant higher
rates of retention and therapy attendance and (b) lower rates of marijuana use compared
to ST group. Due to the limited sample size, a third, non-randomized participant group
was added for comparison purposes—this group included those individuals who failed
their initial drug screen for marijuana but were not consented into the study. The
hypothesis was that the non-randomized participant group would have a reduced
retention rate compared those in the study.
Retention was defined as passing the final mandatory drug test administered by
Job Corp after the probationary period. The differences in retention rates for the three
groups (MET+CM+ST, ST, and not consented) trended towards significance, with 100%
retained for the treatment group, 71.43% for the control group, and 54.55% for the nonrandomized participant control group. And, those in enrolled in the study had
significantly better retention rates in comparison to the non-randomized participant
control group.
Official retention rates were not found to differ significantly between the
MET+CM+ST and ST group, however, this finding may be due to the extensions
granted by the TEAP specialist for those individuals who reported they had failed their
Week 4 study drug screen. In contrast, there were significant differences found between
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the MET+CM+ST group and ST group for those who passed their Week 4 study drug
screen, suggesting a potential treatment effect that should be investigated with a larger
sample. The MET+CM+ST group also demonstrated significantly higher pass rates for
the 3-month drug screen than the ST group, and they reported higher PDA for marijuana
that approached statistical significance (p= 0.055) at the 3-month follow-up.
The improved Job Corps retention rate found in the present study is in accord with
prior clinical trials focusing on MET and substance use, especially those targeted at
reinforcing retention (Hettema et al., 2005). In addition, these findings offer additional
support for the use of CM in improving retention (Higgins et al, 1994; Petry et al, 2005).
However, due to the design of this study, it is impossible to determine whether it was
MET or CM or the combination of those with ST that increased the likelihood of passing
the Week 4 and 3-month follow-up study drug screens.
Participants in the treatment group may have been motivated to succeed not only
because of the rewards provided by the CM component or the heightened awareness
achieved in MET, but also because of their desire to please their therapist. This desire is
evidenced by participants’ statements in relation to their study drug screens such as “I
want you to see that I’ve been good” and “I’m sorry, I’ll pass next week, I promise”,
which may reflect the reporting bias acknowledged in another MET study (Baer et al.,
1992). There were no differences between therapists for retention rates, Week 4 study
drug screen or the 3-month follow-up study drug screen, and feelings of wanting to
please both therapists were expressed during the course of the study. Many participants
came from troubled homes or the foster care system, therefore, the sense of feeling
“special” and wanting to please may have played a significant role in their motivation
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towards abstinence. Working alliance (i.e., the bond between therapist and patient) has
been found to be an effective predictor of post-treatment use in adolescent substance
users (Tetzlaff et al., 2005). Further, the CM component may have reinforced this
connection with the therapist, as it may have signified a reward for this positive
relationship. Also, because all of these individuals came from impoverished
backgrounds, the simple act of earning/getting “gifts” may have been a powerful
motivator or reinforcer to them, perhaps more so than similar rewards for those who are
from more affluent populations. Noteworthy, among cocaine abusers, studies have
demonstrated that CM is equally effective in treating substance users with higher income
levels as lower levels (Rash, Olmstead, & Petry, 2009).
In addition, CM component of this study may have helped improve PDA during
the study not only because of the escalating reward system but also because of the
unexpected requests of many of the participants to “bank” their winnings to purchase
more expensive and more desirable prizes (e.g. Ipods, DVD players). The decision for
delayed reinforcement was an investment that suggested a commitment to maximize their
opportunities to add to their winnings by submitting negative urine samples and attending
therapy sessions, which may have contributed to the high study retention rates. Perhaps
the addition of the option of “banking your winnings” to the typical CM structure may
enhance the effectiveness of CM in future studies, and also brings into question the
general consensus that CM is most effective with those participants who desire
immediate reinforcement (e.g., Griffith, Rowan-Szal, Roark, & Simpson, 2000).
Notably, one of the issues regarding the use of CM in the treatment of substance
use is the cost (Higgins et al., 1994, 2000). This study provides limited evidence for the
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reduction of substance use achieved even when the expected payout is decreased by 20%
($1.60 versus $1.27 expected payout per award) and the time in which rewards are
offered are reduced, 4 weeks versus 3 months. Additional research is needed to
determine if the long term success rates in reducing substance use are similar.
The attendance rate, measured as the percentage of ST sessions attended, did not
differ between the treatment (89.74%, SD 12.99) and control group (78.27%, SD 25.78)
and both were relatively high. The expectation was that the addition of MET+CM to ST
would result in a significantly higher attendance rate than for ST alone. In a population
with similar ages to the Job Corps trainees, Aubrey (1998) reported a doubling of
outpatient substance abuse treatment sessions attended by adolescents given a single
session of MET at intake. Moreover, CM has been shown to improve session attendance
for young adults in marijuana studies (Carroll et al., 2006; Sinha et al., 2003), and in
alcohol treatment settings (Helmus et al., 2003; Petry et al., 2000). However, a prior
study (Budney et al., 2000) demonstrated lower than expected attendance rates in an
MET+CM+CBT group, which was partially attributed to the small voucher amounts and
lower intrinsic motivation to change.
In the current study, the attendance rate for ST was quite high (>75%) for both the
MET+CM+ST group and the ST group, which is perhaps unusual for this historically
apathetic demographic, especially given the relatively small reward payout design ($1.27
expected payout per draw and 84 potential draws for the MET+CM+ST group and 20
potential draws for the ST group). One confounding factor was that the ST participants
earned CM draws for submitting urine tests, albeit designed to have the least impact
possible, this small collateral reinforcement may have improved attendance in the ST.
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Also, this particular population is under much stricter controls than most young substance
users in that their time is structured with adult supervision throughout the day with
classes, meals, and recreational activities, making it difficult to avoid attending the
required ST when on campus. Furthermore, compared to most substance users, those at
Job Corp have the additional motivator to attend the required therapy and stay in the
program rather than return to the streets or to broken homes and lose their housing,
meals, small stipends and vocational and educational training.
Measurements Issues
The ASI is a structured interview that allows for assessment of substance use and
secondary effects associated with drug use (McLellan et al., 1992). The ASI drug
composite and ASI marijuana scores at the 3-month follow-up were statistically lower for
the treatment group than the control group, suggesting fewer marijuana related problems
for the treatment group. These results were similar to one other CM marijuana study
(Carroll et al. 2006); however, in general the composite ASI scores exhibited little
difference between treatment groups in marijuana (Budney et al., 2000, 2006; Sinha et
al., 2003) and alcohol (Petry et al., 2000) studies. Therefore, it is possible that the ASI
may not be the best measure for discerning treatment differences in certain groups.
In addition, depending on the demographics of the participants of a given study,
certain accommodations need to be made to normalize the ASI composite scores. For
example, individuals under probation-referred treatment may have mandatory court
appearances that will inflate their Legal Composite, and pregnant women or people with
a pre-existing medical condition may make more frequent medical appointments than a
nominally healthy individual. In addition, the family/social score is biased against those
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who are homeless or come from bad family situations, and drug use may not be the full
reason for their family issues.
In addition, psychometric properties for the ASI in relation to adolescents have
not been researched adequately, and the ASI does not account for individuals in
controlled environments, such as inpatient substance abuse programs or those in a
confined vocational training program. Consequently, care must be taken when applying
the ASI to groups that do not fit the 'general population' demographics. For instance,
Sinha et al. (2003) used the standard research ASI in their study of marijuana treatment
for probation-referred young adults, and this may not have been the best method for this
population to assess psychosocial difficulties related to their drug use.
In spite of these criticisms, the ASI has become the de facto measure of
consequences related to drug use, and is strongly recommended to be included in research
supported by federal funding agencies when conducting addictions research. Therefore,
although the ASI has some limitations, it is highly regarded, and was included in this
study.
Limitations of the Study
There were several limitations of the study that need to be addressed in future
research. First, a larger sample size is needed to adequately test the hypotheses. Also,
due to unexpected complications relating to study therapists, randomization to therapist
had to be compromised. At the beginning of the study, participants were randomly
assigned via urn randomization to balance on: gender, ethnicity, total months of
addiction(s) and therapist. However, due to unexpectedly having to replace one therapist
with another who was under time constraints, the first seven participants were
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randomized to either treatment or control group by gender, ethnicity, and total months of
addiction and more heavily weighted to the new therapist if assigned to the treatment
group. Also, three months into the study there were unexpected time limitations imposed
on the duration of the study by the Job Corps due to supervisory issues, and participants
were then alternatively assigned to either the control group or treatment group based on
entry into Job Corps to ensure equal representation for both groups. In addition, the
participants unexpectedly reported their drug screen results to the TEAP counselor, and
were often granted extensions for their final retest, thereby compromising the study’s
measure of retention in Job Corps. Furthermore, the researcher who conducted the 3month follow-ups was not blind to study conditions, introducing potential reporting bias.
Finally, longer term follow-ups of 6- to 12-months would be useful to ascertain delayed
treatment effects or changes in overall behavior.
Challenges of Conducting Research in the Field
One of the significant contributions of this study is that it brought empirically
supported treatment into a real world, non-clinical treatment setting. However, there
were many challenges of conducting this study in the field. Due to the nature of the
setting, a federally funded vocational program, additional time and compromises were
required to obtain initial approval to conduct this study, and Job Corps was able to
enforce an unexpected mandatory study end date three months into the study, which
limited and greatly shortened the recruitment time (6 months versus an unlimited amount
of time). Also, this particular center unexpectedly reached maximum capacity early on
in the study, and subsequently became much stricter about whom they allowed into the
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program. As a result, they were able to screen out many who would typically fail their
initial drug screen, which greatly limited recruitment activity.
In addition, since many participants reported their drug screen results to the TEAP
specialist, and were often granted extensions for their final retest, the study’s primary
measure of Job Corps retention rate was compromised. However, the participants
benefited personally because they were able to monitor their urine screens via the study
and were aware if they would fail if tested by Job Corps, and these extensions made it
possible for many to stay in the program, which was ultimately in their best interest,
though admittedly not in the best interest of the study. Noteworthy, these extensions
were granted in part because this program is federally funded and a portion of their
funding is based on their actual retention of students, therefore they did not always
adhere to their “zero tolerance” policy for substance use.
Further, substance using teenagers and young adults are typically considered a
difficult population to treat as they are often either in the contemplation or even
precontemplation stage of change (Sinha et al., 2003; Walker et al., 2006), and are not yet
actively preparing for change. Moreover, since most of the participants lived on campus
and spent the majority of their time together, there may have been greater peer pressure to
use substances since substances were widely available on campus. Additional
unexpected challenges of conducting this study in a real life setting included: one
participant in the treatment group found out she was pregnant and her motivation for
abstinence was most likely based on the health of her child and not due to any treatment
intervention; two participants in the control group became actively suicidal (not study
related) and required brief interventions by the researcher due to the lack of mental health
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care available to them; and, there were problems associated with the lack of mandatory
on-site supervision for the study therapists.
Clinical Implications
To the extent that that findings can be generalized from such a small sample, this
study provides the first limited evidence that the population of marijuana-using
adolescents and young adults enrolled in Job Corps responds well to both MET and CM.
The nonconfrontational, client-centered philosophy of MI was easily embraced by this
population. The majority of treatment participants arrived enthusiastic for their sessions,
engaged actively in the treatment process, and appeared to enjoy the positive relationship
with their therapist. And, in general, study participants became quite animated and
excited about the CM portion of the study. All of these individuals came from
impoverished backgrounds and many had little experience with being positively
reinforced for good behavior, therefore they were enthusiastic about the opportunity to
get material items that were reinforcing to them, and to be acknowledged for being
responsible and making better life choices in relation to their substance use. Noteworthy,
the majority opted for delayed reinforcement for their awards, demonstrating an
unexpected finding of discipline, as substance users are often thought of as desiring
immediate reinforcement. Further, this study may suggest that trainees who can simply
monitor drugs in their system on a weekly basis may be more likely to achieve abstinence
as it makes them more accountable to themselves and/or to the researcher or therapist; or
perhaps the tests simply give frequent, concrete evidence of positive life choices, which
further encourages abstinence.
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Future Directions
Based on this study, there are many areas in need of further investigation for
treating substance using adolescents and young adults in the Job Corps setting. First and
foremost, larger study groups would provide greater confidence in the findings of this
study. A 2x2 study design that included 4 groups: ST, ST+MET, ST+CM, and
ST+MET+CM would allow one to separate the effects of ST, MET and CM. Further, 6and 12-month follow-up periods would allow for the investigation of delayed treatment
effects, and preferable, those follow-ups should be conducted by a researcher blind to
study conditions. And, implementing ‘booster’ MET sessions over a 12 month period
may help in maintaining the gains achieved during the first 4 weeks of the study.
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Appendix A Schedule of Assessments
SCHEDULE OF ASSESSMENTS



Quick Screen
Structured Clinical
Interview for DSM-IV
Axis I Disorders
(Substance Abuse and
Dependence/ Psychosis)
Consent Form



HIPAA Authorization



Locator Form
Demographic Form
Form 90/ Time-Line
Follow Back
ASI
SOCRATES
Urine Drug Screen/ Mouth
Swab










TOTAL EXPECTED TIME
(Minutes):

Minutes

Preassessment
(Week 0)

2
20

♦
♦

10
5
2
3
30/5

♦
♦
♦
♦
♦

30
5
5

Weekly
(Weeks 1-4)

PostAssessment
(Week 4)

3 month
Follow-Up
(Week 12)

♦

♦

♦

♦
♦
♦

♦

♦
♦
♦

♦
♦
♦

112

10

45

60
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Appendix B Screening Form for Potential Participants

Study: Job Corps
ID:
Date:

SCREENING FORM
1.

Are you over 18 years of age or considered legally emancipated by New Mexico
State Law?

YES ____

NO____

If no, would you be willing and able to get parental/guardian permission to
participate in this study?

This would require them knowing that you tested

positive for drugs upon entering the Job Corps.
YES ____
2.

NO____ (discontinue)

Are you currently in your probationary period at the Job Corps and are you enrolled
in the TEAP program?

3.

YES ____ NO____ (discontinue)

Did you test positive for marijuana within the first 48 hours of being at the
Albuquerque Center (“initial drug screen”), or do you have a marijuana problem?
YES ____

4.

NO____ (discontinue)

Do you have a current or past gambling problem?
YES ____ (discontinue)

5.

NO____

Have you ever been diagnosed with any type of psychosis, or thought disorder (e.g.
Schizophrenia, Bipolar, etc)?
YES ____ (discontinue, if not currently controlled for by medication and also
meet the requirement for an active thought disorder according to the SCID)
NO____

* Emancipation: In New Mexico, an “emancipated minor” is an individual under 18 years of age
and meets one of the following criteria: is or ever has been married; currently serving in the U.S.
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military; or is 16 or17 and has been emancipated by Court Order, and that order does not exclude
the minor from making health care decisions for himself or herself.

If eligible for the study, then say:
This study asks participants to describe their drug use experiences in a confidential, individual
manner, fill out several questionnaires, and submit breath and urine screens on 6 different
occasions. Please understand, absolutely everything will be kept confidential, that is, your name
will not appear on your forms that contain drug use information or your urine results. There is
nothing in this study that will negatively impact your place at the Job Corps in any manner—that
means, you cannot be kicked out of the Job Corps for any information submitted during this
research study!

There will be a 4 week treatment period, and during this time you have a 50% chance of
attending weekly 50-minute psychotherapy sessions in addition to your required therapy in
TEAPS. These sessions will be used to better understand your values and motivation for change
and drug use.

A breath and urine sample will be collected weekly and your attendance cards for therapy in
TEAPS will be reviewed. Everyone in the study submits this information weekly.

In addition, everyone will receive the opportunity to win prizes—however, for those assigned to
receive additional weekly therapy sessions (50%), you must be abstinent and complete activities
(for example, attending your required TEAPS therapy on-time and attending our therapy session
on-time) in order to have the opportunity to win prizes. For the others, simply submitting urine
screens and therapy attendance cards each week, regardless of outcome, will have the
opportunity to win prizes, though they will have much fewer chances. Are you okay with this?

Lastly, 1 hour posttreatment assessments will occur on Week 4 and 12 after completion of the
treatment phase in which you would be asked to fill out many of the same assessments and submit
a breath and urine screen. Would you be willing to participate?
If yes, continue with the informed consent, and assessments, or schedule an appointment for
the pre-assessment in the next 48 hours.
Day and time scheduled _______________
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Appendix C Screening Questions From Modules of SCID

SCREENING SCID QUESTIONS
Study: Job Corps
ID:
Date:
SCID-CV: Quick Screen
B. PSYCHOTIC AND ASSOCIATED SYMPTOMS
SCID
Question

DSM Criteria: Delusions

Meets
Criteria

B1

Delusion of reference

Y

N

B2

Persecutory delusion

Y

N

B3

Grandiose delusion

Y

N

B4

Somatic delusion

Y

N

B5

Other delusions

Y

N

B6

Auditory hallucinations

Y

N

B7

Visual hallucinations

Y

N

B8

Tactile hallucinations

Y

N

B9

Other hallucinations

Y

N

B10

Y

N

Y

N

B12

Catatonic behaviors
Grossly disorganized
behavior
Grossly inappropriate
affect

Y

N

B13

Disorganized speech

Y

N

B14

Negative symptoms
IF DELUSIONS OR
HALLUCINATIONS HAVE
EVER BEEN PRESENT,
FILL OUT CHRONOLOGY
SECTION

Y

N

B11

B15

Notes
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SCID-CV: Quick Screen
DISORDERS
SCID
Question
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Brief description

E. ALCOHOL AND OTHER SUBSTANCE USE

DSM Criteria
History of excessive
drinking OR evidence of
alcohol-related problems

Meets
Criteria

Y

DSM Criteria: Alcohol
Abuse
A. Maladaptive pattern of
alcohol use, leading to
clinically significant
impairment or distress,
as manifested by 1 (or
more) of the following
occurring within a 12month period:
A1. failure to fulfill major
role obligations at work,
E2
school or home
Y
A2. use in situations in
E3
which it is physically
Y
hazardous
A3. recurrent alcoholE4
related legal problems
Y
A4. continued alcohol
use despite having
problems caused or
E5
exacerbated by the
Y
effects of alcohol
AT LEAST 1 ABUSE
E6
ITEM
Y
(E2-E5)
SCID-CV: Quick Score
E. ALCOHOL AND

Notes

N

N
N

N

N

N
OTHER SUBSTANCE USE
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DISORDERS
SCID
Question

E7

E8

E9

E10

E11

DSM Criteria:
Alcohol Dependence
A. Maladaptive pattern of
alcohol use, leading to
clinically significant
impairment or distress,
as manifested by 3 (or
more) of the following,
occurring at any time in
the same 12-month
period
A3. often taken in larger
amounts OR over a longer
period than was intended
A4. there is a persistent
desire OR unsuccessful
effort to cut down or
control alcohol use
A5. a great deal of time is
spent in activities
necessary to obtain
alcohol, use alcohol, or
recover from its effects
A6. important social,
occupational, or
recreational activities are
given up or reduced
because of use
A7. continued use despite
knowledge of having a
persistent or recurrent
physical or psychological
problems

Meets
Criteria

Y

N

Y

N

Y

N

Y

N

Y

N

E12

A1. tolerance

Y

N

E13

A2. withdrawal
AT LEAST 3
DEPENDENCE ITEMS
(E7-E13) OCCURRING
WITHIN THE SAME 12MONTH PERIOD

Y

N

Y

N

E15

Alcohol Dependence

Y

N

E16

Alcohol Abuse

Y

N

E14

Notes
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E. ALCOHOL AND OTHER SUBSTANCE USE

DSM Criteria:
Meets
Nonalcohol Substance
Criteria
Notes
Use Disorders
CIRCLE THE NAME OF
DOCUMENT HISTORY OF
EACH DRUG EVER USED
DRUG USAGE
Sedatives-hypnoticsanxiolytics: Quaalude,
Seconal, Valium, Xanax,
Librium, barbiturates,
Miltown, Ativan, Dalmane,
Y
N
Halcion, Restoril, other
(specify)
Cannabis: marijuana,
hashish, THC, other
Y
N
(specify)
Stimulants: amphetamine,
"speed", crystal meth,
dexadrine, Ritalin, "ice",
Y
N
other (specify)
Opioids: heroin,
morphine, opium,
Methadone, Darvon,
codeine, Percodan,
Demerol, Dilaudid,
Y
N
unspecified or other
(specify)
Cocaine: intranasal, IV,
freebase, crack,
"speedball", unspecified or
Y
N
other (specify)
Hallucinogens/PCP: LSD,
mescaline, peyote,
psilocybin, STP,
mushrooms, PCP ("angel
dust"), Special K
Y
N
(ketamine), Ecstasy,
MDMA, other (specify)
Other: steroids, "glue",
paint, inhalants, nitrous
oxide ("laughing gas"),
amyl or butyl nitrate
("poppers"),
nonprescription sleep or
Y
N
diet pills, unknown or
other (specify)
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Drugs with heaviest use
/ most problems
SCID-CV: Quick Score
E. ALCOHOL AND OTHER SUBSTANCE USE
DISORDERS
E17

SCID
Question

DSM Criteria:
Meets
Nonalcohol Substance
Criteria
Notes
Abuse
A. Maladaptive pattern of
substance use leading to
clinically significant
impairment or distress,
as manifested by one (or
more) of the following
occurring within a 12month period
A1. failure to fulfill major
role obligations at work,
E18
school or home
Y
N
A2. use in situations in
E19
which it is physically
Y
N
hazardous
A3. recurrent substanceE20
related legal problems
Y
N
A4. continued substance
use despite having
problems caused or
E21
exacerbated by the
Y
N
effects of substance
AT LEAST 1 ABUSE
E22
ITEM
Y
N
(E18-E21)
SCID-CV: Quick Score
E. ALCOHOL AND OTHER SUBSTANCE USE
DISORDERS
SCID
Question

DSM Criteria:
Nonalcohol Substance
Dependence
A. Maladaptive pattern of
substance use, leading to
clinically significant
impairment or distress,
as manifested by three (or
more) of the following,
occurring at any time in
the same 12-month
period
A3. often taken in larger
amounts OR over a longer

Meets
Criteria

Notes
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period than was intended
A4. there is a persistent
desire OR unsuccessful
effort to cut down or
control substance use
A5. a great deal of time is
spent in activities
necessary to obtain
substance, use
substance, or recover
from its effects
A6. important social,
occupational, or
recreational activities are
given up or reduced
because of use
A7. continued use despite
knowledge of having a
persistent or recurrent
physical or psychological
problems

Y

N

Y

N

Y

N

Y

N

Y

N

E28

A1. tolerance

Y

N

E29

A2. withdrawal
AT LEAST 3
DEPENDENCE ITEMS
(E23-E29) OCCURRING
WITHIN THE SAME 12MONTH PERIOD

Y

N

Y

N

E31

Substance Dependence

Y

N

E32

Substance Abuse

Y

N

E24

E25

E26

E27

E30
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Appendix D Informed Consent

CONSENT TO PARTICIPATE IN RESEARCH
• INTRODUCTION
You are asked to participate in a research study conducted by Julie Steele, M.S., principal
investigator and graduate student from the Psychology Department at the University of
New Mexico, entitled “Eliciting Abstinence and Improving Retention in a Vocational
and Educational Training Program for Young People: A Pilot Study.”
The results of this study will contribute to her dissertation. You were selected as a
possible participant in this study because you responded to a request by your TEAPS
counselor for interested participants who have either tested positive for illicit drugs at the
Albuquerque Job Corps Center in your initial drug screen, or were self-referred to the
program in your first 7 days at the Job Corps.
• PURPOSE OF THE STUDY
The purpose of this research is to investigate the effect of Motivational Enhancement
Therapy (MET) and Contingency Management (CM) in addition to the TEAPS treatment
program, specifically looking at therapy attendance, abstinence, and staying in the Job
Corps after the probationary period.
• PROCEDURES
After signing the informed consent and the HIPAA authorization form, a demographics
questionnaire will be used to collect basic data (name, age, and ethnicity), and then a
locator form will be filled out. You will then be given a numerical ID that will be used
on questionnaires and drug screen results, and this information will be kept in your
therapist’s office at the Mental Health Center in a locked file cabinet. All information
identifying you by name (the brief screen, demographics, and informed consent) will be
kept in a separate locked file cabinet in the office of the Mental Health Director, Dr.
Howard M. Ottenheimer.
Next, you will complete three (3) assessments. A time line follow-back interview will be
used to collect information on the types and frequency of use of illicit drugs and alcohol,
in the past 3 months (approximately 30 minutes). A short form will be used to assess
readiness to change substance abuse behaviors (10 minutes). And a final assessment will
be done to see how your substance using behaviors may affect other areas of your life (30
minutes). These questionnaires were chosen to assess the degree to which substances are
being used, current level of functioning, consequences of use on your life, and motivation
to change. Finally, you will be asked to submit a mouth swab (for alcohol) and
urine sample (for illicit drugs).
After completing the assessments and submitting a urine and mouth swab, you will then
be randomized and notified as to which group you will be assigned to, and an
appointment for either your first individual therapy session or meeting with a researcher
will be scheduled. The total amount of time for this initial assessment is 2 hours, though
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it may be shorter or longer. Breaks, snacks, and sodas will be offered during this period,
and if you would prefer, it could be completed over two sessions rather than one.
As mentioned during the brief screen, this study consists of a 4 week treatment period,
and 50% of participants will receive one (1), 50-minute psychotherapy session each week
in addition to their regular required participation in TEAPS. These sessions will be used
to better understand your values and motivation for changing your drug using behaviors.
This portion of your treatment will be provided by either a master or doctoral level
therapist. Please note, audio recording will be used for all MET therapy sessions to make
sure the therapist is providing the best care possible and these tapes will be labeled with
only your numerical I.D.
A mouth swab (for alcohol) and urine sample (for illicit drugs) will be collected before
each session. Everyone in the study is required to submit drug screens and therapy
attendance cards on 6 different occasions.
In addition, for those receiving additional weekly therapy, they will receive the added
opportunity to win prizes as a reward for weekly abstinence from alcohol and marijuana,
and attendance (attending all weekly required TEAPS sessions, group and individual
therapy, and the individual MET therapy session). However, for those not assigned to
additional weekly therapy sessions, they also will receive opportunities to win prizes
simply based on submitting drug tests and attendance cards, regardless of outcome, but
they will have fewer opportunities.
After you complete your required drug re-test at the Wellness Center (on approximately
day 38 from your entry into the Job Corps), you will then be asked to repeat the same 3
questionnaires, and submit a mouth swab and urine sample within 1 week. In addition,
you will be asked to return in 7 weeks from the day of mandatory re-test to repeat the
questionnaires, mouth swab, and urine sample. The total amount of time schedule for
each is 1 ½ hours for each of those post-assessments, though will most likely be shorter.
Regardless of treatment group, you will receive 20 chances to win prizes for completing
each follow-up assessment. The total amount of time you will be connected with this
research study is 3 months.

• CM WITH PRIZES
Again, only 50% of the participants in this study will be randomized to receive prizes
based on abstinence and therapy attendance, and 50% will receive the opportunity to win
prizes simply for submitting drug screens and attendance cards. The process and rules
will be fully explained by the assigned therapist or researcher. Briefly, participants who
earn an “award” will draw two chips out of a bag and attempt to match any of three
colors: two white chips will represent a $1 prize; 2 blue chips a $20 prize; and 2 red chips
a $100 prize. If two chips of different colors are drawn, the individual will not win
anything. This study will use a chip bag that will always contain 500 chips in which 405
(81%) are white, 75 (15%) are blue, and 20 (4%) are red, and you must draw two chips in
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a row of the same color to win a prize. The chance of winning a blue or red prize, and
therefore winning a $20 prize is 2.25% (about 2 out of 100) and a $100 prize is
0.16% (less than 1 out of 100) for each award, so the chances of winning ‘big’ are
very, very low.
The average award (where an award is drawing two chips) is $1.27. With an average
award of $1.27, and the opportunity to win no more than 84 awards throughout the four
week study for the group required to attend additional weekly therapy, the most they
could earn, on average, is $106.68 in prizes; and for the group not required to attend
additional weekly therapy, the most they could earn is 20 awards and on average, $25.40
in prizes. However, this amount could be more or less depending on how many awards
are earned and chance or ‘luck’. All prizes will be given out right away, and will be
chosen together by the participants and researchers to support a drug-free lifestyle.

• CONFIDENTIALITY
Any information obtained in connection with this study that can be identified with you
will remain confidential and will be disclosed only with your permission. In an effort to
protect your privacy, employability, and reputation, a Federal Certificate of
Confidentiality was issued by the National Institutes of Health (NIH) for this study. This
certificate protects sensitive identifiable information, such as drug use behaviors, from
being released to any federal, state or local agencies, including Job Corps’ employees and
administrators as long as the certificate remains in effect. However, it does not protect
from information requested to be released by your written consent.
Absolutely no records identifying you by name will be kept with your actual data,
questionnaires, urine and/or breathe sample results, and no information with your name
on it will be shared with individuals outside of this research project. This information
will be kept in a locked file cabinet in your therapist’s office. Every effort will be made
to sure that nothing you submit or disclose in this research project can or will be used
against you (e.g., being forced to exit the program due to a positive urinalysis).
Your name will be replaced by a number that will be your personal identification number.
All drug related material pertaining to you will be kept in a secure locked cabinet with
only your numerical I.D. and kept separate from all the forms with your actual name. Dr.
Ottenheimer will keep all forms with your name on it in a separate locked file cabinet in
his office (brief screen, informed consent, and demographics).
The only people that will have access to this research data will be Julie Steele, MS and
her supervisors Barbara McCrady, Ph.D., Jane Ellen Smith, Ph.D., G. Will Goodall,
Ph.D., and Timothy Goldsmith, Ph.D. Julie Steele and Howard Ottenheimer, Ph.D. are
the only people from the Job Corps that will ever see your personal information.

• PARTICIPATION AND WITHDRAWAL
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You can choose whether to participate in this study or not. If you volunteer to
participate, you may withdraw at any time without penalty or loss of benefits to which
you might otherwise be entitled. You may also refuse to answer any questions you do
not want to answer and still stay in the study. The investigator may withdraw you from
this research if circumstances arise which warrant doing so (e.g., threatening behavior).
By signing this consent form, you are not waiving any legal claims, rights or remedies
because of your participation in this research study, and nothing in this study will affect
your Job Corps opportunities.

• POTENTIAL RISKS AND DISCOMFORTS
There is risk involved in participating in this study. While every precaution will be taken
to ensure your confidentiality at all times and your name will never be directly connected
with any of your actual drug using behaviors, it still might be possible for someone not
connected to this study to gain access to your data and identify you, and this may cause
difficulties for you, including legal difficulties or expulsion from the Job Corps.
You are not guaranteed to be in the group with 4 individual therapy sessions. However,
for those of you assigned to receive weekly MET sessions, they are designed for you to
better explore and understand your values, and while doing so you may experience
distress. If this occurs, you may request additional consultation with Dr. Ottenheimer or
any other therapist available at the Job Corps, or you may reschedule your MET session
with no penalty.
Also, due to the duration and intensity of the assessments, you may become bored or
restless; therefore you may request a break at any time or complete the assessments over
two sessions rather than one. Refreshments will be available.
• POTENTIAL BENEFITS TO PARTICIPANTS AND/OR TO SOCIETY
There are a few potential benefits for your participation in this study. You may find that
while exploring your values, you will find greater motivation to change your drug using
behaviors, and by making changes, have a better opportunity to remain active at the Job
Corps.
You also may appreciate the opportunity to participate in a study that may ultimately
affect the type of therapeutic treatment other incoming Job Corp trainees receive who are
attempting to overcome their drug using behaviors.
In addition, if you would like a copy of the results of this study, the researcher will be
happy to provide one for you at the completion of the study. Beyond these potential
benefits, there are no other foreseeable benefits to you.

• IDENTIFICATION OF INVESTIGATORS AND REVIEW BOARD
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If you have any questions or concerns about this research, please feel free to contact:
Julie M. Steele, MS, Intern/Researcher, Job Corps, Student Development Building, 1500
Indian School Rd. NW, Albuquerque, NM 87104 or call (505) 222-4244. Also, you may
reach her at the Department of Psychology, MSC03 2220, 1 University of New Mexico,
Albuquerque, NM 87131-0001 (505) 277-9528, jmsteele@unm.edu.
Or
Clinical supervisor, Howard M. Ottenheimer, Ph.D., Mental Health Consultant, Job
Corps, Student Development Building, 1500 Indian School Rd. NW, Albuquerque, NM
87104 or call (505) 222-4172.
Or
Barbara McCrady, Ph.D., Dissertation Chair, Department of Psychology, MSC03 2220, 1
University of New Mexico, Albuquerque, NM 87131-0001 or call (505) 277-8857.

If you have other concerns or complaints, please contact the Institutional Review Board
at the University of New Mexico, Tim J. Ward, Ph.D., P.E., 1717 Roma NE, Room 205,
Albuquerque, NM 87131, (505) 277-2328.
SIGNATURE OF RESEARCH PARTICIPANT
I understand the procedures described above. My questions have been answered to my
satisfaction, and I agree to participate in this study. I have been provided a copy of this
form.
_______________________________
Name of Participant (please print)
__________________________________________________________
Signature of Participant
Date

SIGNATURE OF INVESTIGATOR
In my judgment the participant is voluntarily and knowingly giving informed consent and
possesses the legal capacity to give informed consent to participate in this research study
__________________________________________________________
Signature of Investigator or Designee
Date
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Appendix E Informed Consent for Parent or Guardian

CONSENT FOR MINOR TO PARTICIPATE IN RESEARCH
• INTRODUCTION
Your minor is asked to participate in a research study conducted by Julie Steele, M.S.,
principal investigator and graduate student from the Psychology Department at the
University of New Mexico, entitled “Eliciting Abstinence and Improving Retention in
a Vocational and Educational Training Program for Young People: A Pilot Study.”
The results of this study will contribute to her dissertation. Individuals were selected as
possible participants in this study because they responded to a request by the Job Corps’
counselor for interested participants who have either tested positive for illicit drugs at the
Albuquerque Job Corps Center in their initial drug screen, or were self-referred to the
program in their first 7 days at the Job Corps.
• PURPOSE OF THE STUDY
The purpose of this research is to investigate the effect of Motivational Enhancement
Therapy (MET) and Contingency Management (CM) in addition to the TEAPS treatment
program, specifically looking at therapy attendance, abstinence, and staying in the Job
Corps after the probationary period.
• PROCEDURES
After you sign the informed consent and HIPAA authorization form, your minor will then
sign a similar form stating they are willing participants in this study. They will then
complete a locator form and demographics questionnaire that will be used to collect basic
data (name, age, and ethnicity). And at that point your minor will be given a numerical
ID that will be used on questionnaires and drug screen results, and this information will
be kept in the therapist’s office at the Mental Health Center in a locked file cabinet. All
information identifying your minor by name (the brief screen, demographics, and
informed consent) will be kept in a separate locked file cabinet in the office of the Mental
Health Director, Dr. Howard M. Ottenheimer.
Next, your minor will complete three (3) assessments. A time line follow-back interview
will be used to collect information on the types and frequency of use of illicit drugs and
alcohol, in the past 3 months (approximately 30 minutes). A short form will be used to
assess readiness to change substance using behaviors (10 minutes). And a final
assessment will be administered to see how their substance using behaviors may affect
other areas of your life (30 minutes). These questionnaires were chosen to assess the
degree to which substances are being used, current level of functioning, consequences of
use on their life, and motivation to change. Finally, your minor will be asked to submit
a mouth swab (for alcohol) and urine sample (for illicit drugs).
After completing the assessments and submitting a urine and mouth swab, they will then
be randomized and notified as to which group they will be assigned to, and an
appointment for their first session will be scheduled. The total amount time scheduled
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for this initial assessment is 2 hours, though it may be shorter or longer. Breaks, snacks,
and sodas will be offered during this period, and if they prefer, the assessment could be
completed over two sessions rather than one.
This study consists of a 4 week treatment period, and 50% of participants will receive one
(1), 50-minute psychotherapy session each week in addition to their regular required
participation in TEAPS. These sessions will be used to better understand your minor’s
values and motivation for changing their drug using behaviors. This portion of their
treatment will be provided by either a master or doctoral level therapist. Please note,
audio recording will be used for all MET therapy sessions to make sure the therapist is
providing the best care possible and these tapes will be labeled with only your minor’s
numerical I.D.
A mouth swab (for alcohol) and urine sample (for illicit drugs) will be collected before
each session. Everyone in the study is required to submit drug screens and therapy
attendance cards on 6 different occasions.
In addition, for those receiving additional weekly therapy, they will receive the added
opportunity to win prizes as a reward for weekly abstinence from alcohol and marijuana,
and attendance (attending all weekly required TEAPS sessions, group and individual
therapy, and the individual MET therapy session). However, for those not assigned to
additional weekly therapy sessions, they also will receive opportunities to win prizes
simply based on submitting drug tests and attendance cards, regardless of outcome, but
they will have fewer opportunities.

After they complete the mandatory drug re-test at the Wellness Center (on approximately
day 38 from their entry into the Job Corps), they will then be asked to repeat the same 3
questionnaires, and submit a mouth swab and urine sample within 1 week. In addition,
they will be asked to return in 7 weeks from their mandatory re-test to repeat these
questionnaires, mouth swab, and urine sample. The total amount of time scheduled for
each is 1 ½ hours for the post-assessments, though will be most likely shorter.
Regardless of treatment group, your minor will receive 20 chances to win prizes for
completing each follow-up assessment. The total amount of time your minor will be
connected with this research study is 3 months.
• CM GROUP WITH PRIZES
Again, only 50% of the participants in this study will be randomized to receive prizes
based on abstinence and therapy attendance, and 50% will receive the opportunity to win
prizes simply for submitting drug screens and attendance cards. The process and rules
will be fully explained by the assigned therapist or researcher. Briefly, participants who
earn an “award” will draw two chips out of a bag and attempt to match any of three
colors: two white chips will represent a $1 prize; 2 blue chips a $20 prize; and 2 red chips
a $100 prize. If two chips of different colors are drawn, the individual will not win
anything. This study will use a chip bag that will always contain 500 chips in which 405
(81%) are white, 75 (15%) are blue, and 20 (4%) are red, and they must draw two chips
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in a row of the same color to win a prize. The chance of winning a blue or red prize,
and therefore winning a $20 prize is 2.25% (about 2 out of 100) and a $100 prize is
0.16% (less than 1 out of 100) for each award, so the chances of winning ‘big’ are
very, very low.
The average award (where an award is drawing two chips) is $1.27. With an average
award of $1.27, and the opportunity to win no more than 84 awards throughout the four
week study for the group required to attend additional weekly therapy, the most they
could earn, on average, is $106.68 in prizes; and for the group not required to attend
additional weekly therapy, the most they could earn is 20 awards and on average, $25.40
in prizes. However, this amount could be more or less depending on how many awards
are earned and chance or ‘luck’. All prizes will be given out right away, and will be
chosen together by the participants and researchers to support a drug-free lifestyle.
• CONFIDENTIALITY
Any information obtained in connection with this study that can be identified with your
minor will remain confidential and will be disclosed only with both your and their
permission. In an effort to protect their privacy, employability, and reputation, a Federal
Certificate of Confidentiality was issued by the National Institutes of Health (NIH) for
this study. This certificate protects sensitive identifiable information, such as drug use
behaviors, from being released to any federal, state or local agencies, including Job
Corps’ employees and administrators as long as the certificate remains in effect. It does
not protect from information requested to be released by both you and your minor’s
written consent.
Absolutely no records identifying your minor by name will be kept with their actual data,
questionnaires, urine and/or breathe sample results, and no information with their name
on it will be shared with individuals outside of this research project. This information
will be kept in a locked file cabinet in their therapist’s office. Every effort will be made
to be sure that nothing they submit or disclose in this research project can or will be used
against them (e.g., being forced to exit the program due to a positive urinalysis).
Their name will be replaced by a number that will be their personal identification
number. All drug related material pertaining to your minor will be kept in a secure
locked cabinet separate from all the forms with their actual name. Dr. Ottenheimer will
keep all forms with their name on it in a separate locked file cabinet in his office (brief
screen, informed consent, and demographics).
The only people that will have access to this research data will be, Julie Steele, MS and
her supervisors Barbara McCrady, Ph.D., Howard Ottenheimer, Ph.D., Jane Ellen Smith,
Ph.D., G. Will Goodall, Ph.D., and Timothy Goldsmith, Ph.D. Howard Ottenheimer,
Ph.D. and Julie Steele are the only people from the Job Corps that will ever see your
minor’s individual data.

• PARTICIPATION AND WITHDRAWAL
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You and your minor can choose whether they will participate in this study or not. If they
volunteer to participate with your informed consent, they may withdraw at any time
without penalty or loss of benefits to which they might otherwise be entitled, and you
may choose for them to stop participation at any time with no penalty to your minor.
They may also refuse to answer any questions they do not want to answer and still stay in
the study. The investigator may withdraw them from this research if circumstances arise
which warrant doing so (e.g., threatening behavior). By signing this consent form, you or
they are not waiving any legal claims, rights or remedies because of their participation in
this research study, and nothing in this study will affect their Job Corps opportunities.

• POTENTIAL RISKS AND DISCOMFORTS
There is risk involved in participating in this study. While every precaution will be taken
to ensure your minor’s confidentiality at all times and their name will never be directly
connected with any of their actual drug using behaviors, it still might be possible for
someone not connected to this study to gain access to their data and identify them, and
this may cause difficulties for them, including legal difficulties or expulsion from the Job
Corps.
Your minor also is not guaranteed to be in the group with 4 individual therapy sessions.
However, the MET sessions are designed for them to better explore and understand their
values, and while doing so they may experience distress. If this occurs, they may request
additional consultation with Dr. Ottenheimer or any other therapist available at the Job
Corps, or they may reschedule their MET session with no penalty.
Also, due to the duration and intensity of the assessments, they may become bored or
restless; therefore they may request a break at any time or complete the assessments over
two sessions rather than one. Refreshments will be available.
• POTENTIAL BENEFITS TO PARTICIPANTS AND/OR TO SOCIETY
There are a few potential benefits for their participation in this study. They may find that
while exploring their values, they will find greater motivation to change their drug using
behaviors, and by making changes, have a better opportunity to remain active at the Job
Corps.
They also may appreciate the opportunity to participate in a study that may ultimately
affect the type of therapeutic treatment other incoming Job Corp trainees receive who are
attempting to overcome their drug using behaviors.
In addition, if you or they would like a copy of the results of this study, the researcher
will be happy to provide one at the completion of the study. Beyond these potential
benefits, there are no other foreseeable benefits.

• IDENTIFICATION OF INVESTIGATORS AND REVIEW BOARD
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If you have any questions or concerns about this research, please feel free to contact:
Julie M. Steele, MS, Intern/Researcher, Job Corps, Student Development Building, 1500
Indian School Rd. NW, Albuquerque, NM 87104 or call (505) 222-4244. Also, you may
reach her at the Department of Psychology, MSC03 2220, 1 University of New Mexico,
Albuquerque, NM 87131-0001 (505) 277-9528, jmsteele@unm.edu.
Or
Clinical supervisor, Howard M. Ottenheimer, Ph.D., Mental Health Consultant, Job
Corps, Student Development Building, 1500 Indian School Rd. NW, Albuquerque, NM
87104 or call (505) 222-4172.
Or
Barbara McCrady, Ph.D., Dissertation Chair,. Department of Psychology, MSC03 2220,
1 University of New Mexico, Albuquerque, NM 87131-0001 or call (505) 277-8857

If you have other concerns or complaints, please contact the Institutional Review Board
at the University of New Mexico, Tim J. Ward, Ph.D., P.E., 1717 Roma NE, Room 205,
Albuquerque, NM 87131, (505) 277-2328.
SIGNATURE OF PARENT/GUARDIAN
I understand the procedures described above. My questions have been answered to my
satisfaction, and I give permission for my minor, __________________________to
participate in this study. I have been provided a copy of this form.
_______________________________
Name of Parent/Guardian (please print)
__________________________________________________________
Signature of Parent/Guardian
Date

SIGNATURE OF INVESTIGATOR
In my judgment the parent/guardian is voluntarily and knowingly giving informed
consent for their minor and possesses the legal capacity to give informed consent for their
minor to participate in this research study
__________________________________________________________
Signature of Investigator or Designee
Date
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Appendix F Informed Assent for Minor

ASSENT TO PARTICIPATE IN RESEARCH
• INTRODUCTION
My name is Julie Steele. I am a graduate student from the Psychology Department at the
University of New Mexico, and I am conducting a research study entitled “Eliciting
Abstinence and Improving Retention in a Vocational and Educational Training
Program for Young People: A Pilot Study.”
The results of this study will contribute to my dissertation. You were selected as a
possible participant in this study because you responded to a request by your TEAPS
counselor for interested participants who have either tested positive for illicit drugs at the
Albuquerque Job Corps Center in your initial drug screen, or were self-referred to the
program in your first 7 days at the Job Corps.
• PURPOSE OF THE STUDY
The purpose of this research is to investigate the effect of Motivational Enhancement
Therapy (MET) and Contingency Management (CM) in addition to the TEAPS treatment
program, specifically looking at therapy attendance, abstinence, and staying in the Job
Corps after the probationary period.
• PROCEDURES
After obtaining your parent or guardian’s signature representing their informed consent
for you to participate in this study and HIPAA authorization, and your signature on this
form representing your voluntary willingness to participate in this study, a demographics
questionnaire will be used to collect basic data (name, age, and ethnicity) and locator
form will be filled out.
You will then be given a numerical ID that will be used on questionnaires and drug
screen results, and this information will be kept in the your therapist’s office at the
Mental Health Center in a locked file cabinet. All information identifying you by name
(the brief screen, demographics, and informed consent) will be kept in a separate locked
file cabinet in the office of the Mental Health Director, Dr. Howard M. Ottenheimer.
Next, you will complete three (3) assessments. A time line follow-back interview will be
used to collect information on the types and frequency of use of drugs and alcohol, in the
past 3 months (approximately 30 minutes). A short form will be used to assess readiness
to change substance abuse behaviors (10 minutes). And a final assessment will be done
to see how your substance using behaviors may affect other areas of your life (30
minutes). These questionnaires were chosen to assess the degree to which substances are
being used, current level of functioning, consequences of use on your life, and motivation
to change. Finally, you will be asked to submit a mouth swab (for alcohol) and
urine sample (for illicit drugs).
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After completing the assessments and submitting a urine and mouth swab, you will then
be randomized and notified as to which group you will be assigned to, and an
appointment for either your first MET session or meeting with a researcher will be
scheduled. The total amount time scheduled for this initial assessment is 2 hours, though
it may be shorter or longer. Breaks, snacks, and sodas will be offered during this period,
and if you would prefer, it could be completed over two sessions rather than one.
As mentioned during the brief screen, this study consists of a 4 week treatment period,
and 50% of participants will receive one (1), 50-minute psychotherapy session each week
in addition to their regular required participation in TEAPS. These sessions will be used
to better understand your values and motivation for changing your drug using behaviors.
This portion of your treatment will be provided by either a master or doctoral level
therapist. Please note, audio recording will be used for all MET therapy sessions to make
sure the therapist is providing the best care possible and these tapes will be labeled with
only your numerical I.D.
In addition, for those receiving additional weekly therapy, they will receive the added
opportunity to win prizes as a reward for weekly abstinence from alcohol and marijuana,
and attendance (attending all weekly required TEAPS sessions, group and individual
therapy, and the individual MET therapy session). However, for those not assigned to
additional weekly therapy sessions, they also will receive opportunities to win prizes
simply based on submitting drug tests and attendance cards, regardless of outcome, but
they will have fewer opportunities. Individuals will be randomly assigned to treatment
groups via a computer program.
After you complete your required drug re-test at the Wellness Center (on approximately
day 38 from your entry into the Job Corps), you will then be asked to repeat the same 3
questionnaires, and submit a mouth swab and urine sample within 1 week. In addition,
you will be asked to return in 7 weeks from the day of mandatory re-test to repeat the
questionnaires, mouth swab, and urine sample. The total amount of time schedule for
each is 1 ½ hours for each of those post-assessments, though will most likely be shorter.
Regardless of treatment group, you will receive 20 chances to win prizes for completing
each follow-up assessment. The total amount of time you will be connected with this
research study is 3 months.

• CM GROUP WITH PRIZES
Again, only 50% of the participants in this study will be randomized to receive prizes
based on abstinence and therapy attendance, and 50% will receive the opportunity to win
prizes simply for submitting drug screens and attendance cards. The process and rules
will be fully explained by the assigned therapist or researcher. Briefly, participants who
earn an “award” will draw two chips out of a bag and attempt to match any of three
colors: two white chips will represent a $1 prize; 2 blue chips a $20 prize; and 2 red chips
a $100 prize. If two chips of different colors are drawn, the individual will not win
anything. This study will use a chip bag that will always contain 500 chips in which 405
(81%) are white, 75 (15%) are blue, and 20 (4%) are red, and you must draw two chips in
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a row of the same color to win a prize. The chance of winning a blue or red prize, and
therefore winning a $20 prize is 2.25% (about 2 out of 100) and a $100 prize is
0.16% (less than 1 out of 100) for each award, so the chances of winning ‘big’ are
very, very low.
The average award (where an award is drawing two chips) is $1.27. With an average
award of $1.27, and the opportunity to win no more than 84 awards throughout the four
week study for the group required to attend additional weekly therapy, the most they
could earn, on average, is $106.68 in prizes; and for the group not required to attend
additional weekly therapy, the most they could earn is 20 awards and on average, $25.40
in prizes. However, this amount could be more or less depending on how many awards
are earned and chance or ‘luck’. All prizes will be given out right away, and will be
chosen together by the participants and researchers to support a drug-free lifestyle.
• CONFIDENTIALITY
Any information obtained in connection with this study that can be identified with you
will remain confidential and will be disclosed only with your permission. In an effort to
protect your privacy, employability, and reputation, a Federal Certificate of
Confidentiality was issued by the National Institutes of Health (NIH) for this study. This
certificate protects sensitive identifiable information, such as drug use behaviors, from
being released to any federal, state or local agencies, including Job Corps’ employees and
administrators as long as the certificate remains in effect. It does not protect from
information voluntarily released by your written consent.
Absolutely no records identifying you by name will be kept with your actual data,
questionnaires, urine and/or breathe sample results, and no information with your name
on it will be shared with individuals outside of this research project. This information
will be kept in a locked file cabinet in your therapist’s office. Every effort will be made
to be sure that nothing you submit or disclose in this research project can or will be used
against you (e.g., being forced to exit the program due to a positive urinalysis).
Please note, information gathered in this study will not be shared with your parent or
guardian without first obtaining your written permission.
Your name will be replaced by a number that will be your personal identification number.
All drug related material pertaining to you will be kept in a secure locked cabinet
separate from all the forms with your actual name. Dr. Ottenheimer will keep all forms
with your name on it in a separate locked file cabinet in his office (brief screen, informed
consent, and demographics).
The only people that will have access to this research data will be, Julie Steele, MS and
her supervisors Barbara McCrady, Ph.D., Howard Ottenheimer, Ph.D., Jane Ellen Smith,
Ph.D., G. Will Goodall, Ph.D., and Timothy Goldsmith, Ph.D. Howard Ottenheimer,
Ph.D. and Julie Steele are the only people from the Job Corps that will ever see your
individual data.
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• PARTICIPATION AND WITHDRAWAL
If you don’t want to be in this study, you don’t have to participate. Remember, being in
this study is up to you and no one will be upset if you don’t want to participate or even if
you change your mind later and want to stop.
Since you are a minor, your parent or guardian can also require you to withdraw at
anytime. The investigator may withdraw you from this research if circumstances arise
which warrant doing so (e.g., threatening behavior). By signing this consent form, you
are not waiving any legal claims, rights or remedies because of your participation in this
research study, and nothing in this study will affect your Job Corps opportunities.
Please talk this over with your parents before you decide whether or not to participate.
We will also ask your parents to give their permission for you to take part in this study.
But even if your parents say “yes”, you can still decide not to do this.
You can ask any questions that you have about the study. If you have a question later
that you didn’t think of now, you can call me 505-362-8765 or ask me next time.
Signing your name at the bottom means that you agree to be in this study. You and your
parents will be given a copy of this form after you have signed it.

• POTENTIAL RISKS AND DISCOMFORTS
There is risk involved in participating in this study. While every precaution will be taken
to ensure your confidentiality at all times and your name will never be directly connected
with any of your actual drug using behaviors, it still might be possible for someone not
connected to this study to gain access to your data and identify you, and this may cause
difficulties for you, including legal difficulties or expulsion from the Job Corps.
You are not guaranteed to be in the group with 4 individual therapy sessions. However,
for those of you assigned to receive weekly MET sessions, they are designed for you to
better explore and understand your values, and while doing so you may experience
distress. If this occurs, you may request additional consultation with Dr. Ottenheimer or
any other therapist available at the Job Corps, or you may reschedule your MET session
with no penalty.
You also are not guaranteed to be in the group eligible to win prizes, and therefore the
primary potential benefit to you would be 4 individual therapy sessions.
Also, due to the duration and intensity of the assessments, you may become bored or
restless; therefore you may request a break at any time or complete the assessments over
two sessions rather than one. Refreshments will be available.
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• POTENTIAL BENEFITS TO PARTICIPANTS AND/OR TO SOCIETY
There are a few potential benefits for your participation in this study. You may find that
while exploring your values, you will find greater motivation to change your drug using
behaviors, and by making changes, have a better opportunity to remain active at the Job
Corps.
You also may appreciate the opportunity to participate in a study that may ultimately
affect the type of therapeutic treatment other incoming Job Corp trainees receive who are
attempting to overcome their drug using behaviors.
In addition, if you would like a copy of the results of this study, the researcher will be
happy to provide one for you at the completion of the study. Beyond these potential
benefits, there are no other foreseeable benefits to you.
• IDENTIFICATION OF INVESTIGATORS AND REVIEW BOARD
If you have any questions or concerns about this research, please feel free to contact:
Julie M. Steele, MS, Intern/Researcher, Job Corps, Student Development Building, 1500
Indian School Rd. NW, Albuquerque, NM 87104 or call (505) 222-4244. Also, you may
reach her at the Department of Psychology, MSC03 2220, 1 University of New Mexico,
Albuquerque, NM 87131-0001 (505) 277-9528, jmsteele@unm.edu.
Or
Clinical supervisor, Howard M. Ottenheimer, Ph.D., Mental Health Consultant, Job
Corps, Student Development Building, 1500 Indian School Rd. NW, Albuquerque, NM
87104 or call (505) 222-4172.
Or
Barbara McCrady, Ph.D., Dissertation Chair, Department of Psychology, MSC03 2220, 1
University of New Mexico, Albuquerque, NM 87131-0001 or call (505) 277-8857.

If you have other concerns or complaints, please contact the Institutional Review Board
at the University of New Mexico, Tim J. Ward, Ph.D., P.E., 1717 Roma NE, Room 205,
Albuquerque, NM 87131, (505) 277-2328.
SIGNATURE OF RESEARCH PARTICIPANT
I understand the procedures described above. My questions have been answered to my
satisfaction, and I agree to participate in this study. I have been provided a copy of this
form.
________________________________________
Name of Participant (please print)
__________________________________________________________
Signature of Participant
Date
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SIGNATURE OF INVESTIGATOR
In my judgment the participant is voluntarily and knowingly giving informed assent and
has obtained informed consent from there parent or guardian to participate in this
research study
__________________________________________________________
Signature of Investigator or Designee
Date
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Appendix G HIPAA Authorization

UNIVERSITY OF NEW MEXICO
MAIN CAMPUS INSTITUTIONAL REVIEW BOARD
HIPAA1 AUTHORIZATION TO USE AND DISCLOSE
INDIVIDUAL HEALTH INFORMATION FOR RESEARCH PURPOSES
1. Authorization. As a research participant, you authorize Julie M. Steele, MS and the researcher’s staff to
use and disclose your individual health information for the purpose of conducting the research project
entitled “Eliciting Abstinence and Improving Retention in a Vocational and Educational Training
Program for Young People: A Pilot Study.”
2. Information to be Use or Disclosed. Your individual health information that may be used or disclosed
to conduct the study includes: demographic information, drug use information, and previous medical
conditions.
3. Parties Authorized to Disclose Information. The researcher and the researcher’s staff may obtain your
individual health information from: ___________________________________________
4. Parties Who May Receive or Use Information. Your individual health information disclosed by parties
listed in item three and information disclosed by you or discovered about you during the course of the
research may be received and used by Julie M. Steele, MS and the researcher’s staff .
5. Right to Refuse to Sign this Authorization. You understand that you do not have to sign this
Authorization. If you do not sign, then you will not be allowed to participate in the study or receive any
treatment that may be provided through the study. However, your decision not to sign this Authorization
will not affect any other treatment, payment, or enrollment in health plans or eligibility for benefits.
6. Right to Withdraw Authorization. You understand you can change your mind and withdraw this
Authorization at any time by sending a written notice to Julie M. Steele, MS (Job Corps, Student
Development Building, 1500 Indian School Rd. NW, Albuquerque, NM 87104) to inform the researcher
of your decision. If you withdraw this Authorization, the researcher may only use and disclose individual
health information already collected for the study. No additional health information about you will be
collected by or disclosed to the researcher for the study.
7. Potential Re-disclosure. Your individual health information disclosed under this Authorization may be
subject to re-disclosure outside the research study and no longer protected under certain circumstances such
as mandated reporting of abuse or neglect, and for health oversight activities and public health purposes.
8. Suspension of Access to Health Records. You understand that you may not be allowed to review
information collected about you for this study, including information recorded in your medical record, until
the study is completed. When the study is over you will have the same rights to access the information as
you had before enrolling in the study.
9. Expiration of Authorization. This authorization does not have an expiration date.

1 HIPAA

is the Health Insurance Portability and Accountability Act of 1996, a federal law related to
privacy of health information.
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I am the research participant or the personal representative authorized to act on behalf of the participant. I
have read this information, and I understand I will receive a copy of this Authorization when it has been
signed.

_________________________
Name of Subject (type or print)

_________________________
Name of Legal Representative
(Legal guardian, authorized surrogate under Uniform Health Care Decisions Act)

___________________________________________________________________
Describe authority of personal representative to act on behalf of the research subject

________________________________________
Signature of Subject or Legal Representative

______________
Date
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Appendix H Demographic Questionnaire

Study: Job Corps
ID:
Date:
CASAA Research Division

DEMOGRAPHIC INTERVIEW 2.2—Modified
1.
Gender: ___(1) Male ___(2) Female
2.
Your Age: ________ Years
3.
Where do you live? ___ (1) On-campus ___ (2) Off-campus
4.
Ethnic Group (check all that apply)
____(1) American Indian or Alaskan Native
____(2) Asian, Asian-American, or Pacific Islander
____(3) Black or African-American
____(4) Hispanic, Cuban
____(5) Hispanic, Mexican
____(6) Hispanic, New Mexican (or Spanish-American)
____(7) Hispanic, Puerto-Rican
____(8) Hispanic, Other Latin American
____(9) White, not of Hispanic origin
____(0) Some other ethnic group
If Other (0) please specify: ___________________________________________
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Appendix I Locator Form
Study: Job Corps
Name:
Date:
LOCATOR FORM

Please list two individuals that you would feel comfortable for a researcher to contact and
request information regarding your location in the event that you leave the Job Corps
before the end of this study (3 months from today). Either one or both of these
individuals would be contacted and the only statement that would be made is the
following:
“Hello, my name is (researcher’s first name) and I work with the Job Corps. (Your
name) gave me permission to contact you regarding getting back in touch with him/her
for some follow-up information. Would you please ask (your name) to contact me as
soon as possible, my number is 505-362-8765, thank you!”
No additional information would be shared.

1.)

Name:
Address:
Telephone Number:
E-mail:

2.)

Name:
Address:
Telephone Number:
E-mail:
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Appendix J Name-Identification Number Form

NAME-NUMERICAL I.D. FORM

Participant’s Name:

Identification Number:

Assigned Therapist: □ Julie Steele □ Kathy Wiggins
Assigned Treatment Group: □ MET+CM+ST

□ ST
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Appendix K Drug Screen Results Card

DRUG SCREEN RESULTS CARD

Participant’s Numerical I.D: __________________________
Date: ______________________________
Week: □ 0, □ 1, □ 2, □3, □4, or □12
Urine Test: □ Negative for marijuana
□ Positive for marijuana
Mouth Swab: □ Negative for alcohol
□ Positive for alcohol
Therapist/Researcher Signature:
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Appendix L Form 90-DI/Form 90-DF
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Appendix M SOCRATES 7DS/ 7AS
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Appendix N ASI-Lite
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Appendix O Standard Treatment Attendance Cards

TRAINEE’S NAME:

Week 1:

THERAPY

□ Group Therapy (AA/NA)
□ Group Therapy (Relapse
Prevention)

Week 2:

□ Group Therapy (Drug &
Alcohol Prevention)
□ Group Therapy (AA/NA)
□ Group Therapy (Relapse
Prevention)

Week 3:
Week 4:

□ Group Therapy (Drug &
Alcohol Prevention)
□ Individual Therapy
□ Individual Therapy

COUNSELOR’S SIGNATURES
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Appendix P Values Card Sort Instructions

Personal Values Card Sort Instructions (modified)
W.R. Miller, J. C’de Baca, D.B. Matthews and P.L. Wilbourne
University of New Mexico, 2001

1. Place five anchor cards in order from 1-5 in front of the participant (Least
important should be on the left; Most important on the right).
2. Shuffle the 50 value cards; keep the 2 blank cards separate.

3. Instruct the participant to sort the cards using the following script: “I placed
three title cards in front of you—important to me, very important to me, and not
very important to me. I’m going to give you a stack of 50 cards. Each card
describes something that may represent a personal value for you. I would like you
to look at each card and place each card under one of the three title cards. There
are also two blank cards. If there is a value you would like to include, write it on
the card and put it in whichever pile you would like. I would like you to sort all
50 cards, but whether you use the two additional cards is optional. The only rule
is that you can have no more than 10 cards under the Most Important stack. After
you are finished with this part, I will ask you to do one other small task. Do you
have any questions?”
4. When participant indicates s/he is finished with the sorting, look at the Most
Important deck to make sure there are no more than 10 cards under this deck.

5. Read the following: “For the second task, I’d like you to focus on the top
values you chose and sort them from 1 to n (total number participant has in the
most important pile—no more than 10) using the ranking sheet. In this spot (point
to #1) you will put the card that is your top value. Then you will put your second
top value here (point to #2). Do you have any questions?”
6. When participant indicates s/he is finished rank ordering the most important
pile, check to make sure you understand how the cards were sorted (ascending or
descending). Point to the #1 spot and say, “I just want to make sure I have this
right--Is this your number one value”

7. Record values on scoring sheet using either card number or value name.
Indicate which stack each value was put under and for stack #5 (most important),
indicate rank order. 1= number one value.
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Appendix Q Values Card Sort

W. R. Miller, J. C’de Baca, D.B. Matthews and P.L. Wilbourne
University of New Mexico, 2001
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Appendix R Personal Values Record Form
Study: Job Corps
ID:
Date:

PERSONAL VALUES
Record Form
W. R. Miller, J. C’de Baca, D.B. Matthews and P.L. Wilbourne
University of New Mexico, 2001

Not at all important:
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________

Somewhat important:
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________

Very Important:
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________

Top Ten:
1. _____________
2. _____________
3. _____________
4. _____________
5. _____________
6. _____________
7. _____________
8. _____________
9. _____________
10. _____________

